<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Hyperbaric oxygen therapy for chronic wounds - Kranke, P - 2015 | Cochrane Library</title> <meta content="Hyperbaric oxygen therapy for chronic wounds - Kranke, P - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004123.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Hyperbaric oxygen therapy for chronic wounds - Kranke, P - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004123.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004123.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Hyperbaric oxygen therapy for chronic wounds" name="citation_title"/> <meta content="Peter Kranke" name="citation_author"/> <meta content="University of Würzburg" name="citation_author_institution"/> <meta content="kranke_p@ukw.de" name="citation_author_email"/> <meta content="Michael H Bennett" name="citation_author"/> <meta content="Prince of Wales Clinical School, University of NSW" name="citation_author_institution"/> <meta content="Marrissa Martyn‐St James" name="citation_author"/> <meta content="University of Sheffield" name="citation_author_institution"/> <meta content="Alexander Schnabel" name="citation_author"/> <meta content="University Hospital Münster" name="citation_author_institution"/> <meta content="Sebastian E Debus" name="citation_author"/> <meta content="University Heart Centre, University Clinics of Hamburg‐ Eppendorf" name="citation_author_institution"/> <meta content="Stephanie Weibel" name="citation_author"/> <meta content="University of Würzburg" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD004123.pub4" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/06/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004123.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004123.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004123.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Wound Healing; Chronic Disease; Diabetic Foot [*therapy]; Hyperbaric Oxygenation [adverse effects]; Randomized Controlled Trials as Topic; Varicose Ulcer [*therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004123.pub4&amp;doi=10.1002/14651858.CD004123.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="na56WA6j";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004123\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004123\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","hr","pl","ta","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004123.pub4",title:"Hyperbaric oxygen therapy for chronic wounds",firstPublishedDate:"Jun 24, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Wounds Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004123.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004123.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004123.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004123.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004123.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004123.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004123.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004123.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004123.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004123.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16886 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004123.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0108"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0026"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0027"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-sec-0107"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/appendices#CD004123-sec-0113"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/table_n/CD004123StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/table_n/CD004123StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Hyperbaric oxygen therapy for chronic wounds</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#CD004123-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Peter Kranke</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#CD004123-cr-0003">Michael H Bennett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#CD004123-cr-0004">Marrissa Martyn‐St James</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#CD004123-cr-0005">Alexander Schnabel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#CD004123-cr-0006">Sebastian E Debus</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information#CD004123-cr-0007">Stephanie Weibel</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information/en#CD004123-sec-0122">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 June 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004123.pub4">https://doi.org/10.1002/14651858.CD004123.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004123-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004123-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004123-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004123-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004123-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004123-abs-0001" lang="en"> <section id="CD004123-sec-0001"> <h3 class="title" id="CD004123-sec-0001">Background</h3> <p>Chronic wounds are common and present a health problem with significant effect on quality of life. Various pathologies may cause tissue breakdown, including poor blood supply resulting in inadequate oxygenation of the wound bed. Hyperbaric oxygen therapy (HBOT) has been suggested to improve oxygen supply to wounds and therefore improve their healing. </p> </section> <section id="CD004123-sec-0002"> <h3 class="title" id="CD004123-sec-0002">Objectives</h3> <p>To assess the benefits and harms of adjunctive HBOT for treating chronic ulcers of the lower limb. </p> </section> <section id="CD004123-sec-0003"> <h3 class="title" id="CD004123-sec-0003">Search methods</h3> <p>For this second update we searched the Cochrane Wounds Group Specialised Register (searched 18 February 2015); the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2015, Issue 1); Ovid MEDLINE (1946 to 17 February 2015); Ovid MEDLINE (In‐Process &amp; Other Non‐Indexed Citations, 17 February 2015); Ovid EMBASE (1974 to 17 February 2015); and EBSCO CINAHL (1982 to 17 February 2015). </p> </section> <section id="CD004123-sec-0004"> <h3 class="title" id="CD004123-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing the effect on chronic wound healing of therapeutic regimens which include HBOT with those that exclude HBOT (with or without sham therapy). </p> </section> <section id="CD004123-sec-0005"> <h3 class="title" id="CD004123-sec-0005">Data collection and analysis</h3> <p>Three review authors independently evaluated the risk of bias of the relevant trials using the Cochrane methodology and extracted the data from the included trials. We resolved any disagreement by discussion. </p> </section> <section id="CD004123-sec-0006"> <h3 class="title" id="CD004123-sec-0006">Main results</h3> <p>We included twelve trials (577 participants). Ten trials (531 participants) enrolled people with a diabetic foot ulcer: pooled data of five trials with 205 participants showed an increase in the rate of ulcer healing (risk ratio (RR) 2.35, 95% confidence interval (CI) 1.19 to 4.62; P = 0.01) with HBOT at six weeks but this benefit was not evident at longer‐term follow‐up at one year. There was no statistically significant difference in major amputation rate (pooled data of five trials with 312 participants, RR 0.36, 95% CI 0.11 to 1.18). One trial (16 participants) considered venous ulcers and reported data at six weeks (wound size reduction) and 18 weeks (wound size reduction and number of ulcers healed) and suggested a significant benefit of HBOT in terms of reduction in ulcer area only at six weeks (mean difference (MD) 33.00%, 95% CI 18.97 to 47.03, P &lt; 0.00001). We identified one trial (30 participants) which enrolled patients with non‐healing diabetic ulcers as well as venous ulcers ("mixed ulcers types") and patients were treated for 30 days. For this "mixed ulcers" there was a significant benefit of HBOT in terms of reduction in ulcer area at the end of treatment (30 days) (MD 61.88%, 95% CI 41.91 to 81.85, P &lt; 0.00001). We did not identify any trials that considered arterial and pressure ulcers. </p> </section> <section id="CD004123-sec-0007"> <h3 class="title" id="CD004123-sec-0007">Authors' conclusions</h3> <p>In people with foot ulcers due to diabetes, HBOT significantly improved the ulcers healed in the short term but not the long term and the trials had various flaws in design and/or reporting that means we are not confident in the results. More trials are needed to properly evaluate HBOT in people with chronic wounds; these trials must be adequately powered and designed to minimise all kinds of bias. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004123-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004123-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004123-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004123-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004123-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004123-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004123-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004123-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/ta#CD004123-abs-0008">தமிழ்</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004123-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004123-abs-0003" lang="en"> <h3>Hyperbaric oxygen therapy for treating chronic wounds</h3> <p><b>Background</b> </p> <p>Chronic wounds are wounds that take a long time to heal, do not heal, or recur; these wounds are often ulcers associated with diabetes or arterial or venous disease (poor blood circulation). One characteristic of chronic wounds is that the wound tissues are hypoxic (have low oxygen levels). Chronic wounds are commonly occurring and reduce the quality of life of those affected. </p> <p>Hyperbaric oxygen therapy (HBOT) is a treatment designed to increase the supply of oxygen to wounds that are not responding to other treatments. HBOT involves people breathing pure oxygen in a specially designed compression chamber (such as those used for deep‐sea divers suffering pressure problems after resurfacing). </p> <p><b>Review question</b> </p> <p>Does hyperbaric oxygen therapy (HBOT) increase the rate of healing of people with chronic wounds and reduce the need for partial or total lower limb amputation? Is this treatment safe? </p> <p><b>What we found</b> </p> <p>We included twelve randomised trials (577 participants) in this updated review. Most of the included trials studied foot ulcers in people with diabetes (10 trials).<br/> For diabetes‐related foot ulcers, we found that HBOT seemed to improve the chance of healing in the short term (up to six weeks), but not with longer term follow‐up. HBOT may reduce the number of major amputations in people with diabetes who have chronic foot ulcers.<br/> For chronic wounds caused by disease to the veins of the leg, we found that HBOT may reduce the size of wounds.<br/> For chronic wounds caused by lack of blood supply through the arteries or chronic pressure ulcers, we found no evidence to confirm or refute any effects of HBOT.<br/> We could not assess safety as none of the trials included in our review reported whether there were any major adverse events. </p> <p>This plain language summary is up‐to‐date as of 23/1/15</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004123-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004123-sec-0108"></div> <h3 class="title" id="CD004123-sec-0109">Implications for practice</h3> <section id="CD004123-sec-0109"> <p>There is some evidence that the addition of HBOT to a standard wound care regimen in people with foot ulcers due to diabetes results in a significant improvement in wound healing by six weeks, but this benefit is not evident at longer‐term follow‐up at one year or longer. In terms of amputation, HBOT does not appear to significantly improve the minor amputation rate in people with foot ulcers due to diabetes, while a potentially important effect on major amputation cannot be confirmed on this analysis. These findings are limited by trials recruiting small numbers of participants with diverse wound characteristics and by trial reporting and methodological discrepancies that present the potential to bias results. As such, these findings require a cautious interpretation. To date no informative conclusions regarding the effects of HBOT for chronic wounds with other underlying pathologies can be made. </p> </section> <h3 class="title" id="CD004123-sec-0110">Implications for research</h3> <section id="CD004123-sec-0110"> <p>There is a strong case for further better‐reported, large randomised trials of high methodological rigour in order to define the true extent of benefit from the administration of HBOT. Specifically, more information is required on the subset of disease severity or classification most likely to benefit from this therapy, the time for which we can expect any benefits to persist, and the oxygen dose most appropriate. An economic evaluation should also be undertaken. Any future trials would need to consider in particular: </p> <p> <ul id="CD004123-list-0016"> <li> <p>appropriate sample sizes with power to detect expected differences;</p> </li> <li> <p>careful definition and selection of target participants;</p> </li> <li> <p>appropriate oxygen dose per treatment session (pressure and time);</p> </li> <li> <p>appropriate comparator therapy;</p> </li> <li> <p>use of an effective sham therapy;</p> </li> <li> <p>effective and explicit blinding of outcome assessors and surgeons;</p> </li> <li> <p>appropriate outcome measures including all those listed in this review;</p> </li> <li> <p>careful elucidation of any adverse effects; and</p> </li> <li> <p>the cost‐utility of the therapy.</p> </li> </ul> </p> <p>There is a strong case for investigation of the effects of HBOT on chronic wounds due to venous disease, arterial disease and pressure damage, in large, rigorous randomised clinical trials. Future trials should consider the items and outcomes as stated above for diabetic foot ulcers. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004123-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004123-sec-0015"></div> <div class="table" id="CD004123-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperbaric Oxygen Therapy for chronic wounds</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hyperbaric Oxygen Therapy for chronic wounds</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with chronic wounds<br/> <b>Settings:</b> inpatients and outpatients in a hyperbaric facility<br/> <b>Intervention:</b> Hyperbaric Oxygen Therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Hyperbaric Oxygen Therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Diabetic ulcers healed at 1 year.</b><br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 9.53</b> <br/> (0.44 to 207.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>212<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>115 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1000 per 1000</b><br/> (51 to 1000) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Diabetic ulcers ‐ major amputations</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.36</b> <br/> (0.11 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>312<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>89 per 1000</b><br/> (27 to 284) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Analysis comprises small studies, some with zero events in control arm<br/> <sup>2</sup> small sample size<br/> <sup>3</sup> very large effect: RR &gt;5 </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004123-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004123-sec-0016"></div> <section id="CD004123-sec-0017"> <h3 class="title" id="CD004123-sec-0017">Description of the condition</h3> <p>A chronic wound is any interruption in the continuity of the body's surface that requires a prolonged time to heal, does not heal, or recurs (<a href="./references#CD004123-bbs2-0096" title="WysockiAB . Wound fluids and the pathogenesis of chronic wounds. Journal of Wound, Ostomy, and Continence Nursing1996;23:283‐90. ">Wysocki 1996</a>). For the purpose of this review we have generally defined 'chronic' as those wounds where attempts to heal by means other than hyperbaric oxygen therapy have failed. Chronic wounds arise in a great variety of situations and may be associated with a number of pathological processes. In order to institute appropriate therapy, it is common practice to define such wounds by their most likely aetiology. Thus, wounds developing in the presence of demonstrated arterial insufficiency would be termed 'arterial ulcers' and therapeutic measures would aim to improve ischaemia in the limb in order to promote healing, perhaps through bypass surgery when technically possible (<a href="./references#CD004123-bbs2-0055" title="FowkesF , LengGC . Bypass surgery for chronic lower limb ischaemia. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD002000.pub2] ">Fowkes 2008</a>). In ulcers associated with venous insufficiency, on the other hand, compression bandaging is likely to be more appropriate (<a href="./references#CD004123-bbs2-0079" title="O'MearaS , CullumNA , NelsonEA . Compression for venous leg ulcers. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD000265.pub2] ">O'Meara 2009</a>; <a href="./references#CD004123-bbs2-0054" title="EscaleiraR , CardosoM , RegoJ , MacedoP , MidõesA . Efficacy of a two‐component compression system for the therapy of venous leg ulcers. Journal of Wound Care2010;19(3):104‐9. ">Escaleira 2010</a>). The most common chronic wounds encountered in western medical practice are a consequence of diabetes, arterial and/or venous disease, sustained pressure, and those as a result of therapeutic irradiation for the treatment of tumours. More than one such process may be present in an individual and contribute to the wound and they are more common in the elderly and those with multiple health problems (<a href="./references#CD004123-bbs2-0049" title="DealeyC . The Care of Wounds. Oxford: Blackwell Scientific Publications, 1994. ">Dealey 1994</a>; <a href="./references#CD004123-bbs2-0070" title="LauterbachS , KostevK , KohlmannT . Prevalence of diabetic foot syndrome and its risk factors in the UK. Journal of Wound Care2010;19(8):333‐7. ">Lauterbach 2010</a>). </p> <p>Chronic wounds are common and constitute a significant health problem. The true incidence and impact are difficult to assess accurately given the wide range of disease, the fact that much care is delivered at home and that many wound care products are purchased directly in some countries. While most leg ulcers will be the result of venous insufficiency, about 25% are likely to be arterial (<a href="./references#CD004123-bbs2-0036" title="AnderssonE , HanssonC , SwanbeckG . Leg and foot ulcer prevalence and investigation of the peripheral arterial and venous circulation in a randomised elderly population ‐ an epidemiological survey and clinical investigation. Acta Dermato‐Venerologica1993;73:57‐61. ">Andersson 1993</a>; <a href="./references#CD004123-bbs2-0079" title="O'MearaS , CullumNA , NelsonEA . Compression for venous leg ulcers. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD000265.pub2] ">O'Meara 2009</a>). Wound care in the UK costs in excess of GBP 1 billion per year and therefore treatment options that are both clinically effective and cost‐effective are vital (<a href="./references#CD004123-bbs2-0039" title="BanwellPE . Topical negative pressure therapy in wound care. Journal of Wound Care1999;8:79‐84. ">Banwell 1999</a>). The availability of a great variety of treatment options for chronic wounds is a consequence of the range of different aetiologies. However, there is also a possibility that many of the treatment options are ineffective. By definition, chronic wounds are indolent or progressive and resistant to the wide array of treatments applied. There is a plethora of wound care products available ‐ many at considerable cost. In some areas, dedicated wound care teams have been developed in an attempt to maximise successful healing and contain costs through improved efficiency. </p> <p>Wound management techniques are continuously being developed. Strategies include treatment of the underlying pathology (e.g. optimal diabetes care with blood glucose control, vein surgery, arterial reconstruction), systemic treatment aimed at improving the local wound environment (e.g. nutrition supplements, pentoxifylline, aspirin, flavonoids, thromboxane alpha‐2 agonists, sulodexide) (<a href="./references#CD004123-bbs2-0069" title="LangerG , KnerrA , KussO , BehrensJ , SchlömerGJ . Nutritional interventions for preventing and treating pressure ulcers. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD003216] ">Langer 2003</a>; <a href="./references#CD004123-bbs2-0081" title="PalfreymanSJ , NelsonEA , LochielR , MichaelsJA . Dressings for healing venous leg ulcers. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD001103.pub2] ">Palfreyman 2006</a>; <a href="./references#CD004123-bbs2-0063" title="JullAB , ArrollB , ParagV , WatersJ . Pentoxifylline for treating venous leg ulcers. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD001733.pub2] ">Jull 2007</a>) and local treatment aimed at improving the wound environment (e.g. dressings, negative local pressure, pressure‐relieving mattresses, ultrasound, application of growth factors, skin‐grafting) (<a href="./references#CD004123-bbs2-0064" title="JullAB , RodgersA , WalkerN . Honey as a topical treatment for wounds. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD005083.pub2] ">Jull 2008</a>; <a href="./references#CD004123-bbs2-0091" title="UbbinkDT , WesterbosSJ , EvansD , LandL , VermeulenH . Topical negative pressure for treating chronic wounds. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD001898.pub2] ">Ubbink 2008</a>; <a href="./references#CD004123-bbs2-0033" title="Akbari SariA , FlemmingK , CullumNA , WollinaU . Therapeutic ultrasound for pressure ulcers. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD001275.pub2] ">Akbari Sari 2009</a>; <a href="./references#CD004123-bbs2-0062" title="JonesJE , NelsonEA . Skin grafting for venous leg ulcers. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD001737.pub3] ">Jones 2009</a>; <a href="./references#CD004123-bbs2-0048" title="CullumNA , Al‐KurdiD , Bell‐SyerSEM . Therapeutic ultrasound for venous leg ulcers. Cochrane Database of Systematic Reviews2010, Issue 6. [DOI: 10.1002/14651858.CD001180.pub3] ">Cullum 2010</a>; <a href="./references#CD004123-bbs2-0053" title="EdwardsJ , StapleyS . Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD003556.pub2] ">Edwards 2010</a>; <a href="./references#CD004123-bbs2-0038" title="AzizZ , CullumNA , FlemmingK . Electromagnetic therapy for treating venous leg ulcers. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD002933.pub4] ">Aziz 2011</a>; <a href="./references#CD004123-bbs2-0051" title="DumvilleJC , DeshpandeS , O'MearaS , SpeakK . Foam dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD009111.pub2] ">Dumville 2011a</a>; <a href="./references#CD004123-bbs2-0052" title="DumvilleJC , O'MearaS , DeshpandeS , SpeakK . Hydrogel dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD009101.pub2] ">Dumville 2011b</a>). There are many others. In practice, wound management is often a sequential search for a successful combined approach. </p> <section id="CD004123-sec-0018"> <h4 class="title">Wound types</h4> <section id="CD004123-sec-0019"> <h5 class="title">Diabetic foot ulcer</h5> <p>One particular type of chronic wound often associated with ischaemia is the foot ulcer associated with diabetes. It has been estimated that 2% of the UK population have diabetes, of whom up to 25% experience foot ulceration and in whom the amputation rate is 15 to 70 times that in the general population (<a href="./references#CD004123-bbs2-0087" title="Scottish Intercollegiate Guidelines Network. Management of diabetic foot disease. Implementation of the St. Vincent Declaration. The Care of Diabetic Patients in Scotland1997. ">SIGN 1997</a>; <a href="./references#CD004123-bbs2-0044" title="CalmanK . On the state of the public health. The Annual Report of the Chief Medical Officer of the Department of Health for the Year 1997. London: The Stationery Office, 1998. ">Calman 1998</a>; <a href="./references#CD004123-bbs2-0089" title="SinghN , ArmstrongDG , LipskyBA . Preventing foot ulcers in patients with diabetes. JAMA2005;293:217‐28. ">Singh 2005</a>). In diabetes mellitus, the development of foot ulcers is usually the result of peripheral neuropathy and/or peripheral vascular disease. The annual incidence of foot ulcers among people with diabetes has been variously estimated a between 2.5% to 10.7%, and the annual incidence of amputation is 0.25% to 1.8% (<a href="./references#CD004123-bbs2-0037" title="ApelqvistJ , LarssonJ , AgardhCD . Long‐term prognosis for diabetic patients with foot ulcers. Journal Internal Medicine1993;233:485‐91. ">Apelqvist 1993</a>; <a href="./references#CD004123-bbs2-0071" title="LeeJS , LuM , LeeVS , RussellD , BahrC , LeeET . Lower‐extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes1993;42:876‐82. ">Lee 1993</a>; <a href="./references#CD004123-bbs2-0058" title="HumphreyAR , DowseGK , ThomaK , ZimmetPZ . Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention ‐ a 12‐year follow‐up study in Nauru. Diabetes Care1996;19:710‐4. ">Humphrey 1996</a>; <a href="./references#CD004123-bbs2-0042" title="BoultonJM . The diabetic foot ‐ an update. Foot and Ankle Surgery2008;14:120‐4. ">Boulton 2008</a>). Ulcer care is responsible for a large proportion of the cost of health care for people with diabetes. The relapse rate for diabetic foot ulcers is 66% over five years. Approximately 12% of people with ulcers progress to lower extremity amputation (<a href="./references#CD004123-bbs2-0037" title="ApelqvistJ , LarssonJ , AgardhCD . Long‐term prognosis for diabetic patients with foot ulcers. Journal Internal Medicine1993;233:485‐91. ">Apelqvist 1993</a>). </p> </section> <section id="CD004123-sec-0020"> <h5 class="title">Venous ulcer</h5> <p>Venous ulcers (also known as varicose or stasis ulcers) are caused by venous reflux or obstruction resulting in high venous pressure. Estimates for the prevalence of leg ulcers range between 1.5 and 3 per 1000 population, and 1% to 2% of people will have a venous ulcer at least once during their life (<a href="./references#CD004123-bbs2-0035" title="AmslerF , WillenbergT , BlattlerW . In search of optimal compression therapy for venous leg ulcers: a meta‐analysis of studies comparing divers bandages with specifically designed stockings. Journal of Vascular Surgery2009;50:668‐74. ">Amsler 2009</a>). The rate increases with age to about 20 per 1000 people aged over 80 years (<a href="./references#CD004123-bbs2-0043" title="CallamMJ , RuckleyCV , HarperDR , DaleJJ . Chronic ulceration of the leg: extent of the problem and provision of care. British Medical Journal1985;290:1855‐6. ">Callam 1985</a>). It has been estimated that in the UK, the cost to the NHS of treatment for venous ulcers alone may be GBP 300 to 450 million annually (<a href="./references#CD004123-bbs2-0041" title="BosanquetN . Cost of venous ulcers from maintenance therapy to investment programmes. Phlebology1992;1:44‐6. ">Bosanquet 1992</a>), and that district nurses devote between 25% and 50% of their time to the care of people with ulcers (<a href="./references#CD004123-bbs2-0072" title="LeesTA , LambertD . Prevalence of lower limb ulceration in an urban health district. British Journal of Surgery1992;79:1032‐4. ">Lees 1992</a>). </p> </section> <section id="CD004123-sec-0021"> <h5 class="title">Arterial ulcer</h5> <p>Arterial ulcers are the result of impaired perfusion to the feet or legs and are viewed as one clinical sign of general arteriosclerosis. Intermittent claudication may accompany this disease and can be usually found at earlier stages of the arteriosclerosis, while skin lesions or even necrosis represent an end stage of the peripheral manifestation of general arteriosclerosis. </p> </section> <section id="CD004123-sec-0022"> <h5 class="title">Pressure ulcer</h5> <p>Pressure ulcers (also known as pressure sores, decubitus ulcers and bed sores) may present as broken or necrotic skin, most often extending to the underlying tissue, including muscles and bone. They are caused by unrelieved pressure or friction and can be found predominantly below the waist and at bony prominences (sacrum, heels, hips). Increased age, reduced mobility and malnutrition constitute relevant risk factors, however, their respective impact on the genesis of ulcers remains unknown (<a href="./references#CD004123-bbs2-0034" title="AllmanRM . Pressure ulcer prevalence, incidence, risk factors, and impact. Clinical Geriatric Medicine1997;13:421‐36. ">Allman 1997</a>; <a href="./references#CD004123-bbs2-0083" title="ReddyM , GillSS , KalkarSR , WuW , AndersonPJ , RochonPA . Treatment of pressure ulcers. A systematic review. JAMA2008;300(22):2647‐62. ">Reddy 2008</a>). Pressure ulcers can be viewed as typical complications in all healthcare settings with a prevalence of 6% to 10% in National Health Services hospitals in the UK (<a href="./references#CD004123-bbs2-0078" title="O'DeaK . The prevalence of pressure damage in acute care hospital patients in the UK. Journal of Wound Care1999;8:192‐4. [MEDLINE: ODEA1999] ">O'Dea 1999</a>) </p> </section> </section> </section> <section id="CD004123-sec-0023"> <h3 class="title" id="CD004123-sec-0023">Description of the intervention</h3> <p>Hyperbaric oxygen therapy (HBOT) is a treatment modality that has been used in chronic wounds for about 40 years (<a href="./references#CD004123-bbs2-0068" title="KulonenE , NiinikoskiJ . Effect of hyperbaric oxygenation on wound healing and experimental granuloma. Acta Physiologica Scandinavia1968;73(3):383‐4. ">Kulonen 1968</a>). It is relatively widely available in North America (where there are more than 300 facilities registered with the Undersea and Hyperbaric Medical Society (UHMS)), Russia, China and Cuba, but less well‐established in Europe and Australasia (<a href="./references#CD004123-bbs2-0093" title="Undersea and Hyperbaric Medical Society. Hyperbaric chambers North and Central America. A directory of hyperbaric treatment chambers. Undersea and Hyperbaric Medical Society Publications. Kensington, MD2001. ">UHMS 2001a</a>). Treatment involves placing the patient in a compression chamber, increasing the environmental pressure within the chamber, and administering 100% oxygen for respiration. In this way, it is possible to deliver a greatly increased partial pressure of oxygen to the tissues. Typically, treatments involve pressurisation to between 2.0 and 2.5 atmospheres absolute (ATA) for periods between 60 and 120 minutes once or twice daily. A typical course might involve 15 to 30 such treatments. </p> </section> <section id="CD004123-sec-0024"> <h3 class="title" id="CD004123-sec-0024">How the intervention might work</h3> <p>The rationale for HBOT is that, despite the wide range of causative pathologies, the common denominator in many wounds is tissue hypoxia. Wound healing is a complex and incompletely understood process. While it appears that in acute wounds healing is enabled by the initial hypoxia, low pH and high lactate concentrations found in freshly injured tissue (<a href="./references#CD004123-bbs2-0067" title="KnightonDR , HuntTK , SchueuencstuhlH , HallidayBJ , WerbZ , BandaMJ . Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science1983;221:1283. ">Knighton 1983</a>; <a href="./references#CD004123-bbs2-0061" title="JensenJA , HuntTK , ScheuenstuhlH , BandaMJ . Effect of lactate, pyruvate and pH on secretion of angiogenesis and mitogenesis factors by macrophages. Laboratory Investigations1986;54:574‐8. ">Jensen 1986</a>), some elements of tissue repair are extremely oxygen‐dependent, for example collagen elaboration and deposition by fibroblasts (<a href="./references#CD004123-bbs2-0059" title="HuntTK , PaiMP . The effect of varying oxygen tensions on wound metabolism and collagen synthesis. Surgical Gynaecology and Obstetrics1972;135:561‐7. ">Hunt 1972</a>; <a href="./references#CD004123-bbs2-0076" title="NiinikoskiJ , Gunta‐GrislisBA , HuntTK . Respiratory gas tensions and collagen in infected wounds. Annals of Surgery1972;175:588‐93. ">Niinikoski 1972a</a>) and bacterial killing by macrophages (<a href="./references#CD004123-bbs2-0057" title="HohnDC , MacKayRD , HallidayB , HuntTK . Effect of O2 tension on microbicidal function of leucocytes in wounds and in vitro. Surgical Forum1976;27:18‐20. ">Hohn 1976</a>). In a complicated balance between wound hypoxia and peri‐wound oxygenation, it would seem that successful healing relies on adequate tissue oxygenation in the area surrounding the fresh wound. Certainly, wounds that lie in hypoxic tissue beds are those that most often display poor or absent healing (<a href="./references#CD004123-bbs2-0077" title="NiinikoskiJ , HuntTK . Measurement of wound oxygen with implanted silastic tube. Surgery1972;71:22. ">Niinikoski 1972b</a>; <a href="./references#CD004123-bbs2-0085" title="SheffieldPJ . Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen. Hyperbaric Oxygen Review1985;6:18‐46. ">Sheffield 1985</a>). </p> <p>Some causes of tissue hypoxia will be reversible with HBOT, while some will not. One very common cause for peripheral tissue hypoxia is ischaemia due to large vessel disease. In this situation, although the administration of HBOT will result in very high arterial partial pressures of oxygen, this oxygen will not reach the wound bed due to inadequate perfusion. In other clinical situations the cause of tissue hypoxia may be small vessel disease or oedema, and may be overcome by a high driving pressure of oxygen in the arterial blood. This has been demonstrated in hypoxic tissues where regional perfusion is reasonably preserved, through the use of transcutaneous and implantable oxygen electrodes (<a href="./references#CD004123-bbs2-0085" title="SheffieldPJ . Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen. Hyperbaric Oxygen Review1985;6:18‐46. ">Sheffield 1985</a>). In wound healing, insufficient supply of oxygen may prevent normal healing processes. The intermittent presentation of oxygen to those hypoxic tissues, therefore, may allow a resumption of normal healing. HBOT administration in man has been demonstrated to cause hyper‐oxygenation of tissue, vasoconstriction, fibroblast activation, down‐regulation of inflammatory cytokines, up‐regulation of growth factors, antibacterial effects, potentiation of antibiotics, and a reduction in leukocyte chemotaxis (<a href="./references#CD004123-bbs2-0085" title="SheffieldPJ . Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen. Hyperbaric Oxygen Review1985;6:18‐46. ">Sheffield 1985</a>; <a href="./references#CD004123-bbs2-0082" title="RabkinJM , HuntTK . Infection and oxygen. In: DavisJC , HuntTK editor(s). Problem Wounds. The Role of Oxygen. New York: Elsevier Science, 1988. ">Rabkin 1988</a>; <a href="./references#CD004123-bbs2-0046" title="CianciP , HuntTK . Adjunctive hyperbaric oxygen therapy in the treatment of diabetic wounds of the foot. In: LevinME , O´NealLW , BowkerJH editor(s). The Diabetic Foot. 5th Edition. St. Louis: Mosby Year Book, 1993. ">Cianci 1993</a>; <a href="./references#CD004123-bbs2-0090" title="StevensDL , BryantAE , AdamsK , MaderJT . Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clinical Infectious Diseases1993;17(2):231‐7. ">Stevens 1993</a>; <a href="./references#CD004123-bbs2-0097" title="ZhaoLL , DavidsonJD , WeeSC , RothSI , MustoeTA . Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Archives of Surgery1994;129(10):1043‐9. ">Zhao 1994</a>; <a href="./references#CD004123-bbs2-0040" title="BayatiS , RussellRC , RothAC . Stimulation of angiogenesis to improve the viability of prefabricated flaps. Plastic and Reconstructive Surgery1998;101(5):1290‐5. ">Bayati 1998</a>; <a href="./references#CD004123-bbs2-0050" title="DimitrijevichSD , ParanjapeS , WilsonJR , GracyRW , MillsJG . Effect of hyperbaric oxygen on human skin cells in culture and in human dermal and skin equivalents. Wound Repair and Regeneration1999;7(1):53‐64. ">Dimitrijevich 1999</a>). </p> <p>Oxygen in high doses is toxic to normally perfused tissue, in particular the brain and lungs. Therefore it is not possible to expose patients to typical wound treatment pressures for longer than one to two hours on a regular basis and the question arises as to how such short exposures could be expected to result in a clinical benefit. There are two principal reasons why this might be so. First, elevation of wound oxygen tension may persist for some hours following HBOT and so exert therapeutic effects for rather longer than might be expected (<a href="./references#CD004123-bbs2-0086" title="SiddiquiA , DavidsonJD , MustoeTA . Ischemic tissue oxygen capacitance after hyperbaric oxygen therapy: a new physiologic concept. Plastic and Reconstructive Surgery1997;99:148‐55. ">Siddiqui 1997</a>). Second, there is experimental evidence that repeated 'on‐off' exposures do produce an environment favourable to healing when compared to oxygen or air at normobaric pressure. In a rabbit model where wounds were produced by irradiation to the lower face, <a href="./references#CD004123-bbs2-0074" title="MarxRE , EhlerWJ , TayapongsakP , PierceLW . Relationship of oxygen dose to angiogenesis induction in irradiated tissue. American Journal of Surgery1990;160(5):519‐24. ">Marx 1990</a> assessed the angiogenic properties of normobaric oxygen (100% oxygen at 1 ATA for 90 minutes daily) and hyperbaric oxygen (100% oxygen at 2.4 ATA for 90 minutes daily for 20 days), as compared with air‐breathing controls. Results indicated that normobaric oxygen had no angiogenic properties above the normal revascularisation of irradiated tissue than air‐breathing controls (P = 0.89). Hyperbaric oxygen demonstrated an eight‐ to nine‐fold increased vascular density over both normobaric oxygen and air‐breathing controls (P = 0.001). </p> </section> <section id="CD004123-sec-0025"> <h3 class="title" id="CD004123-sec-0025">Why it is important to do this review</h3> <p>HBOT is always presented as an adjunctive therapy to normal wound care measures, and is not proposed as an alternative therapy capable of inducing healing in the absence of good wound care (<a href="./references#CD004123-bbs2-0092" title="The Hyperbaric Oxygen Therapy Committee of the Undersea and Hyperbaric Medical Society. The Hyperbaric Oxygen Therapy Committee Report. Kensington Ma: The Undersea and Hyperbaric Medical Society, 2001. ">UHMS 2001</a>). Using both clinical assessment and investigations designed to confirm significant peri‐wound hypoxia, hyperbaric practitioners attempt to select those wounds where a response to HBOT is considered likely. Often this decision is based on transcutaneous oxygen measurements of the peri‐wound area, both while air‐breathing at normal pressure and on administration of hyperbaric oxygen. If HBOT can be shown to have a beneficial effect on wound healing, then we hypothesise that the addition of this treatment modality may improve the proportion of wounds that achieve healing and thereby enhance the quality of life in such selected participants. One review suggests the addition of HBOT may reduce the overall costs associated with the treatment of diabetic ulcers (<a href="./references#CD004123-bbs2-0045" title="ChuckAW , HaileyD , JacobsP , PerryDC . Cost‐effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. International Journal of Technology Assessment in Health Care2008;24(2):178‐83. ">Chuck 2008</a>). </p> <p>HBOT is associated with some risk of adverse effects including damage to the ears, sinuses and lungs from the effects of pressure, temporary worsening of short‐sightedness, claustrophobia and oxygen poisoning (<a href="./references#CD004123-bbs2-0047" title="ClarkJM , ThomSR . Oxygen under pressure. In: BrubakkAO , NeumanTS editor(s). Bennett and Elliott's physiology and medicine of diving. 5th Edition. London: Saunders, 2003:358‐418. ">Clarke 2003</a>). Although serious adverse events are rare, HBOT cannot be regarded as an entirely benign intervention. Furthermore, as an adjunct to standard therapy HBOT may be associated with increased costs, and any cost/benefit advantage should be carefully assessed. The administration of HBOT for people with chronic wounds remains controversial. While much of the justification derives from pathophysiology and anecdote, there have been a number of attempts to demonstrate a beneficial effect in formal clinical trials in a variety of disease states. In this review we have limited our interest to those chronic wounds associated with diabetes mellitus, peripheral arterial and venous disease and pressure‐related ulcers. The treatment of wounds related to therapeutic irradiation will be the subject of a separate review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004123-sec-0026" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004123-sec-0026"></div> <p>The aim of this review was to assess the evidence for the benefit of hyperbaric oxygen treatment (HBOT) for the treatment of chronic wounds. Does HBOT: </p> <p> <ul id="CD004123-list-0001"> <li> <p>increase the rate of healing of diabetic foot ulcers?</p> </li> <li> <p>increase the rate of healing of venous leg ulcers?</p> </li> <li> <p>increase the rate of healing of arterial ulcers of the lower limb?</p> </li> <li> <p>increase the rate of healing of pressure ulcers?</p> </li> <li> <p>reduce the proportion of people with diabetic foot ulcers who undergo partial or total amputation of the lower limb? </p> </li> <li> <p>reduce the proportion of people with arterial ulcers of the lower limb who undergo partial or total amputation of the lower limb? </p> </li> </ul> </p> <p>Is HBOT safe in the short and long term?</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004123-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004123-sec-0027"></div> <section id="CD004123-sec-0028"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004123-sec-0029"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) that compare the effect on chronic wound healing of treatment with HBOT compared with no HBOT. </p> </section> <section id="CD004123-sec-0030"> <h4 class="title">Types of participants</h4> <p>Any person in any healthcare setting with a chronic wound associated with venous or arterial disease, diabetes mellitus or external pressure. We defined chronic wounds as described in the retrieved papers (prolonged healing or healing by secondary intention), but there must have been some attempt at treatment by other means prior to the application of HBOT. </p> </section> <section id="CD004123-sec-0031"> <h4 class="title">Types of interventions</h4> <p>Wound care regimens which included HBOT compared with similar regimens that excluded HBOT. Where co‐interventions differed significantly between trials we clearly stated this and discussed the implications. </p> <p>HBOT administered in a compression chamber between pressures of 1.5 ATA and 3.0 ATA and treatment times between 30 minutes and 120 minutes daily or twice daily. The comparator group was diverse; we accepted any standard treatment regimen designed to promote wound healing. The salient feature of the comparison group was that these measures had failed before enrolment in the trials. We planned subgroup analysis to evaluate the impact of different comparator strategies. </p> </section> <section id="CD004123-sec-0032"> <h4 class="title">Types of outcome measures</h4> <section id="CD004123-sec-0033"> <h5 class="title">Primary outcomes</h5> <p>Diabetic ulcers:</p> <p> <ul id="CD004123-list-0002"> <li> <p>proportion of ulcers healed;</p> </li> <li> <p>proportion of people undergoing major amputation (defined as amputation of the lower or upper extremity above the ankle or the wrist, respectively). </p> </li> </ul> </p> <p>Venous ulcers:</p> <p> <ul id="CD004123-list-0003"> <li> <p>proportion of ulcers healed.</p> </li> </ul> </p> <p>Pressure ulcers:</p> <p> <ul id="CD004123-list-0004"> <li> <p>proportion of ulcers healed.</p> </li> </ul> </p> <p>Mixed ulcers group:</p> <p> <ul id="CD004123-list-0005"> <li> <p>proportion of ulcers healed.</p> </li> <li> <p>proportion of people undergoing major amputation (defined as amputation of the lower or upper extremity above the ankle or the wrist, respectively). </p> </li> </ul> </p> </section> <section id="CD004123-sec-0034"> <h5 class="title">Secondary outcomes</h5> <p>Diabetic ulcers:</p> <p> <ul id="CD004123-list-0006"> <li> <p>time to complete healing;</p> </li> <li> <p>wound size reduction;</p> </li> <li> <p>proportion undergoing minor amputation (defined as amputation of a hand or foot or any parts of either); </p> </li> <li> <p>quality of life;</p> </li> <li> <p>transcutaneous oxygen tensions and recurrence rate.</p> </li> </ul> </p> <p>Venous ulcers:</p> <p> <ul id="CD004123-list-0007"> <li> <p>time to complete healing;</p> </li> <li> <p>wound size reduction;</p> </li> <li> <p>quality of life;</p> </li> <li> <p>pain;</p> </li> <li> <p>recurrence rate.</p> </li> </ul> </p> <p>Pressure ulcers:</p> <p> <ul id="CD004123-list-0008"> <li> <p>time to complete healing;</p> </li> <li> <p>wound size reduction;</p> </li> <li> <p>quality of life;</p> </li> <li> <p>recurrence rate.</p> </li> </ul> </p> <p>Mixed ulcers group:</p> <p> <ul id="CD004123-list-0009"> <li> <p>time to complete healing;</p> </li> <li> <p>wound size reduction;</p> </li> <li> <p>proportion undergoing minor amputation (defined as amputation of a hand or foot or any parts of either); </p> </li> <li> <p>quality of life;</p> </li> <li> <p>transcutaneous oxygen tensions and recurrence rate.</p> </li> </ul> </p> <p>Adverse events of HBOT:</p> <p> <ul id="CD004123-list-0010"> <li> <p>proportion of people with visual disturbance (short and long‐term);</p> </li> <li> <p>barotrauma (aural, sinus, pulmonary in the short and long‐term);</p> </li> <li> <p>oxygen toxicity (short‐term) with respect to HBOT obtained from the included trials;</p> </li> <li> <p>any other adverse events.</p> </li> </ul> </p> <p>We also examined the proportion of people withdrawn from treatment for any reason and planned to relate such withdrawals to the frequency and dose of HBOT where possible. </p> </section> </section> </section> <section id="CD004123-sec-0035"> <h3 class="title">Search methods for identification of studies</h3> <p>The search methods section of the original version of this review can be found in <a href="./appendices#CD004123-sec-0114">Appendix 1</a>. </p> <section id="CD004123-sec-0036"> <h4 class="title">Electronic searches</h4> <p>For this second update we searched the following electronic databases:</p> <p> <ul id="CD004123-list-0011"> <li> <p>The Cochrane Wounds Group Specialised Register (searched 18 February 2015);</p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2015, Issue 1); </p> </li> <li> <p>Ovid MEDLINE (1946 to 17 February 2015);</p> </li> <li> <p>Ovid MEDLINE (In‐Process &amp; Other Non‐Indexed Citations, 17 February 2015);</p> </li> <li> <p>Ovid EMBASE (1974 to 17 February 2015);</p> </li> <li> <p>EBSCO CINAHL (1982 to 17 February 2015).</p> </li> </ul> </p> <p>We used the following search strategy in the Cochrane Central Register of Controlled Trials (CENTRAL): </p> <p>#1 MeSH descriptor: [Chronic Disease] explode all trees 10595<br/> #2 MeSH descriptor: [Wound Healing] explode all trees 4098<br/> #3 #1 and #2 280<br/> #4 MeSH descriptor: [Skin Ulcer] explode all trees 1720<br/> #5 MeSH descriptor: [Diabetic Foot] explode all trees 433<br/> #6 (skin next ulcer*) or (foot next ulcer*) or (diabetic next (foot or feet)) or (leg next ulcer*) or (varicose next ulcer*) or (venous next ulcer*) or (stasis next ulcer*) or (arterial next ulcer*) 2790<br/> #7 ((ischaemic or ischemic) next (wound* or ulcer*)) 88<br/> #8 (bed next sore*) or (pressure next sore*) or (pressure next ulcer*) or (decubitus next ulcer*) 1174<br/> #9 (chronic next wound*) 292<br/> #10 (chronic near ulcer*) 1099<br/> #11 #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 4559<br/> #12 MeSH descriptor: [Hyperbaric Oxygenation] explode all trees 358<br/> #13 hyperbar* next oxygen* 751<br/> #14 high next pressure next oxygen* 18<br/> #15 oxygen*:ti 4393<br/> #16 #12 or #13 or #14 or #15 4549<br/> #17 #11 and #16 113 </p> <p>The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in <a href="./appendices#CD004123-sec-0115">Appendix 2</a>; <a href="./appendices#CD004123-sec-0116">Appendix 3</a> and <a href="./appendices#CD004123-sec-0117">Appendix 4</a> respectively. We combined the Ovid MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision) (<a href="./references#CD004123-bbs2-0073" title="LefebvreC , ManheimerE , GlanvilleJ , on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We combined the Ovid EMBASE and EBSCO CINAHL searches with the trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="./references#CD004123-bbs2-0088" title="Scottish Intercollegiate Guidelines Network (SIGN). Search filters. Available from http://www.sign.ac.uk/methodology/filters.html#random (accessed 17 July 2011). ">SIGN 2011</a>). There were no restrictions with respect to language, date of publication or trial setting. We contacted authors to discuss any ambiguity about the published data. </p> </section> <section id="CD004123-sec-0037"> <h4 class="title">Searching other resources</h4> <p>We searched the bibliographies of all retrieved and relevant publications to identify any further eligible trials. </p> </section> </section> <section id="CD004123-sec-0038"> <h3 class="title" id="CD004123-sec-0038">Data collection and analysis</h3> <section id="CD004123-sec-0039"> <h4 class="title">Selection of studies</h4> <p>For the original version of the review, one review author (MB) was responsible for handsearching and identifying appropriate trials for consideration. Three review authors (PK, MB and IR) independently examined the electronic search results and identified potentially relevant trials. We retrieved all comparative clinical trials identified and judged to be potentially relevant in full and three review authors reviewed them independently, two with content expertise in the treatment of chronic wounds with HBOT, one with content expertise in treating chronic wounds without HBOT. In addition, two of the review authors (MB, IR) have expertise in clinical epidemiology. For the review update, four review authors made trial selection decisions (SW, MB, MMSJ, and AS). </p> </section> <section id="CD004123-sec-0040"> <h4 class="title">Data extraction and management</h4> <p>Using the data extraction form developed for this review, each review author extracted relevant data and made a recommendation for inclusion or exclusion in this review based on an appraisal of the trial methodology. The number of participants originally allocated to the HBOT and control groups was extracted to allow an 'intention‐to‐treat analysis' (ITT) approach in the meta‐analysis (see <a href="#CD004123-sec-0052">Dealing with missing data</a> and <a href="#CD004123-sec-0053">Data synthesis</a>). We identified losses to follow‐up where this information was reported. </p> <p>For the update, MB and SW undertook data extraction and this was checked by PK. We settled any differences by consensus. The data extracted included the following. </p> <p> <ol id="CD004123-list-0012"> <li> <p>Trial authors</p> </li> <li> <p>Year of publication</p> </li> <li> <p>Study design (RCT)</p> </li> <li> <p>Inclusion criteria for participants</p> </li> <li> <p>Baseline characteristics of participants</p> </li> <li> <p>Numbers recruited and allocated</p> </li> <li> <p>Method of randomisation</p> </li> <li> <p>Method of participant allocation</p> </li> <li> <p>Blinding of participants and trial personnel</p> </li> <li> <p>Details of the intervention (treatment and comparator)</p> </li> <li> <p>Setting of treatment</p> </li> <li> <p>Duration of intervention/follow‐up periods</p> </li> <li> <p>Outcomes measured</p> </li> <li> <p>Number of participants completing</p> </li> <li> <p>Reporting of withdrawals</p> </li> <li> <p>Reasons for participant withdrawal</p> </li> <li> <p>Statistical methods used in the analysis</p> </li> <li> <p>Methods for handling missing data (per‐protocol or ITT analysis)</p> </li> <li> <p>Results per group for each outcome</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> </section> <section id="CD004123-sec-0041"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We appraised each included trial to assess the risk of bias as outlined in section 8.5 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004123-bbs2-0056" title="HigginsJPT , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and according to the criteria described below. 'Unclear risk' means that insufficient information was available to make a judgement. </p> <section id="CD004123-sec-0042"> <h5 class="title">1. Random sequence generation (selection bias)</h5> <p>Low risk: adequate sequence generation was reported using random number tables, computer random number generator, coin tossing or card/envelope shuffling.<br/> High risk: used a system involving dates, names or admittance numbers for the allocation of participants. We considered such trials as quasi‐randomised and excluded them from the review.<br/> Unclear risk: did not describe one of the adequate methods but mentioned randomisation. </p> </section> <section id="CD004123-sec-0043"> <h5 class="title">2. Allocation concealment (selection bias)</h5> <p>Low risk: a randomisation method was described that would not allow an investigator/participant to know or influence allocation to an intervention group before an eligible participant entered the trial, such as central randomisation or serially numbered, opaque, sealed envelopes.<br/> High risk: an inadequate method of allocation was used, such as alternate medical record numbers or unsealed envelopes; or there was information in the trial report indicating that investigators or participants could have influenced group allocation.<br/> Unclear risk: the trial report mentioned randomisation but there was no information on the method used, or a method was reported that was not clearly adequate. </p> </section> <section id="CD004123-sec-0044"> <h5 class="title">3. Blinding of participants (performance bias and detection bias)</h5> <p>We graded this item as 'low risk' for blinding participants, 'unclear' if the relevant information was not stated in the trial report and 'high risk' for unblinded participants. </p> </section> <section id="CD004123-sec-0045"> <h5 class="title">4. Blinding of outcome assessors (performance bias and detection bias)</h5> <p>We graded this item as 'low risk' for blinded outcome assessment, 'unclear' if the relevant information was not stated in the trial report and 'high risk' for any statement indicating unblinded outcome assessment. </p> </section> <section id="CD004123-sec-0046"> <h5 class="title">5. Incomplete outcome data addressed (description of withdrawals)</h5> <p>Low risk: numbers of withdrawals per group with reasons provided; or clear from report that there were no withdrawals.<br/> High risk: some withdrawal evident but numbers per group and reasons not provided.<br/> Unclear risk: unclear from trial report whether there were any withdrawals. </p> </section> <section id="CD004123-sec-0047"> <h5 class="title">6. Incomplete outcome data addressed (use of intention‐to‐treat (ITT) analysis)</h5> <p>We defined ITT analysis as being conducted when all trial participants were analysed in the group to which they were randomised regardless of which (or how much) of the treatment they actually received, and regardless of other protocol irregularities, such as ineligibility. <br/> Low risk: trial report stated that ITT was undertaken and this was confirmed on trial assessment, or not stated but evident from trial assessment that ITT was undertaken.<br/> High risk: ITT not confirmed on trial assessment (participants who were randomised were not included in the analysis because they did not receive the trial intervention, they withdrew from the trial or were not included because of protocol violation) regardless of whether analysis described as ITT.<br/> Unclear risk: described as ITT analysis, but unable to confirm on trial assessment, or not reported and unable to confirm by trial assessment. </p> </section> <section id="CD004123-sec-0048"> <h5 class="title">7. Selective reporting</h5> <p>We defined selective reporting as whether all outcomes detailed in an original trial protocol were presented in the published report as follows:<br/> Low risk: all outcomes in trial protocol are reported.<br/> High risk: only certain outcomes from the original protocol (for example outcomes with a statistically significant beneficial effect) are reported<br/> Unclear risk: full trial protocol not available (from trial investigators or a trials register).<br/> In the absence of the availability of a full trial protocol for any included report, we noted whether the results section of the published report presented results for all outcomes that were described in the methods section. </p> </section> </section> <section id="CD004123-sec-0049"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004123-sec-0050"> <h5 class="title">Dichotomous data</h5> <p>For the dichotomous outcomes we presented the summary estimate as a risk ratio (RR) with 95% confidence intervals (CI). We estimated the RR using the intention‐to‐treat (ITT) data of the treatment group (HBOT) compared with the ITT of the control group. The dichotomous outcomes included the following. </p> <p> <ol id="CD004123-list-0013"> <li> <p>Wounds healed</p> </li> <li> <p>Major amputations</p> </li> <li> <p>Minor amputations</p> </li> <li> <p>Ulcer recurrence</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> <p>In the original review we presented a RR of failing to heal. For this update, we presented the RR of healing in order to facilitate ease of interpretation for the reader of the healing outcomes. The interpretation of the RR was that a summary estimate in which HBOT increased the occurrence of healing would have a RR &gt; 1.00 and a summary estimate in which HBOT reduced the occurrence of amputation, ulcer recurrence or adverse events would have a RR &lt; 1.00. </p> <p>For the dichotomous outcomes, we analysed the number of reported events in each arm against the number of participants originally randomised to that arm at trial enrolment (ITT). We then undertook sensitivity analyses to include people (events) potentially lost to follow‐up (see <a href="#CD004123-sec-0052">Dealing with missing data</a>). </p> </section> <section id="CD004123-sec-0051"> <h5 class="title">Continuous data</h5> <p>Where continuous outcomes were measured in the same way across trials, we presented a mean difference (MD) with 95% CI. We presented a standardised mean difference (SMD) where trials measured the same outcome using different methods. The continuous outcomes included the following. </p> <p> <ol id="CD004123-list-0014"> <li> <p>Time to complete healing</p> </li> <li> <p>Ulcer size reduction</p> </li> <li> <p>Quality of life</p> </li> <li> <p>Transcutaneous oxygen tension</p> </li> <li> <p>Pain</p> </li> </ol> </p> </section> </section> <section id="CD004123-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>For the trials indicating missing data as participants allocated for whom no outcome data were presented, we adopted the ‘best‐case’ and ‘worst‐case’ scenario method cited in section 16.2 in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004123-bbs2-0056" title="HigginsJPT , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The ‘best‐case’ scenario is that all participants with missing outcomes in the experimental intervention group had good outcomes, and all those with missing outcomes in the control intervention group had poor outcomes. The ‘worst‐case’ scenario is the converse. </p> </section> <section id="CD004123-sec-0053"> <h4 class="title">Data synthesis</h4> <p>We undertook statistical pooling using Cochrane RevMan software (version 5.3) (<a href="./references#CD004123-bbs2-0084" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3 beta. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We assessed statistical between‐trial heterogeneity using the I<sup>2</sup> statistic (<a href="./references#CD004123-bbs2-0056" title="HigginsJPT , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We applied a fixed‐effect model where trials examined the same interventions, the populations and methods described were sufficiently similar, and low levels of between‐trial heterogeneity were evident (I<sup>2</sup> ≤ 30%, <a href="./references#CD004123-bbs2-0056" title="HigginsJPT , Altman DG(editors) , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If statistical heterogeneity was detected, we used a random‐effects model to produce an overall summary estimate. As an estimate of the clinical relevance of any difference between experimental intervention and control intervention we calculated the number needed to treat (NNT) with 95% CI as appropriate. We undertook and presented a narrative synthesis of all trials. </p> </section> <section id="CD004123-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Since the obtained NNTs or numbers needed to harm (NNHs) differ depending on the underlying risk for an event in the trial population, we considered subgroup analyses due to different baseline risks, in which case we planned to use 'truncated' data restricting the analyses to a predefined control event rate. </p> <p>Where appropriate data were available, we also considered subgroup analysis based on the following. </p> <p> <ol id="CD004123-list-0015"> <li> <p>Wound entry grade or severity using established wound classification systems where the authors have employed those systems. </p> </li> <li> <p>Dose of oxygen received (pressure, time and length of treatment course).</p> </li> <li> <p>Nature of the comparative treatment modalities.</p> </li> </ol> </p> </section> <section id="CD004123-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>We undertook sensitivity analysis for the effects of missing data, employing the best‐case and worse‐case scenarios as described above. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004123-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004123-sec-0056"></div> <section id="CD004123-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD004123-sec-0058"> <h4 class="title">Results of the search</h4> <p>In our original report, we identified 26 publications dealing with the treatment of chronic wounds with adjunctive HBOT and for the first update we identified a further 25 publications, for the second update we identified a further 24 publications. Initial examination suggested 31 possible comparative trials where systemic hyperbaric oxygen was employed in at least one arm of the trial. After appraisal of the full report for these trials, we excluded 18 publications. Twelve trials met the inclusion criteria for the review. We identified two published protocols to ongoing trials and added those to <a href="./references#CD004123-sec-0130" title="">Characteristics of ongoing studies</a> for consideration in a subsequent update (<a href="./references#CD004123-bbs2-0031" title="O'ReillyD , LindenR , FedorkoL , TarrideJE , JonesWG , BowenJM , et al. A prospective, double‐blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non‐healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Trials2001;12:69. ">O'Reilly 2011</a>; <a href="./references#CD004123-bbs2-0032" title="StoekenbroekRM , SantemaTB , KoelemayMJW , vanHulstRA , LegemateDA , ReekersJA , UbbinkDT . Is additional hyperbaric oxygen therapy cost‐effective for treating ischemic diabetic ulcers? Study protocol for the Dutch DAMOCLES multicenter randomized clinical trial. Journal of Diabetes2015;71:125‐32. ">Stoekenbroek 2015</a>). </p> </section> <section id="CD004123-sec-0059"> <h4 class="title">Included studies</h4> <p>In total, twelve trials contributed to this review and these were published between 1992 (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>) and 2014 (<a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>). In total, these trials include data on 577 participants, 281 receiving HBOT and 267 receiving control or comparator treatment, and the largest (<a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>) accounts for 17% of participants. In the reports of <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> and <a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>, the number of participants randomised to each arm was not specified, and we were unable to obtain this information through contact with the authors. We have assumed an equal distribution for this review. One of the trials included patients with venous ulcers (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>), and one trial included a mixed group of patients with diabetic and venous ulcers (<a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a>), while the other ten included people with diabetic ulcers (See <a href="./references#CD004123-sec-0128" title="">Characteristics of included studies</a>). </p> <section id="CD004123-sec-0060"> <h5 class="title">Diabetic foot ulcers</h5> <p>Ten trials comparing HBOT with control (either with or without sham) enrolling a total of 531 people with diabetic ulcers were included in this analysis (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>; <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>; <a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). The treatment pressure and time schedule used for delivery of oxygen varied between trials. <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> used 3.0 ATA for 45 minutes, while the remainder used between 2.2 and 2.5 ATA for between 60 and 120 minutes. Nine trials gave between 20 and 40 sessions once or twice daily either five or six days each week, whilst one trial (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>) unusually applied four sessions only, over a period of two weeks. Three trials (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>) employed a sham treatment in the control group, on the same schedule as the HBOT group. The other seven trials did not employ a sham therapy (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>; <a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). </p> <p>Inclusion criteria varied in these trials. <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> included any person with diabetes with a chronic foot lesion (time not specified); <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a> included people with diabetes and Wagner grade 2, 3 or 4 lesions (<a href="./references#CD004123-bbs2-0094" title="WagnerFW . The diabetic foot. Orthopedics1987;10(1):163‐72. ">Wagner 1987</a>); <a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a> and <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a> people with "early diabetic feet", Wagner grades 0, 1 or 2, while <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a> and <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> included people with diabetes whose lesions had been present for more than four weeks, six weeks and three months respectively. In addition, <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> required evidence of good standard wound care in a specialist clinic setting for a minimum of two months. Exclusion criteria generally followed from the specific inclusions detailed above, but <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a> also specifically excluded participants for whom vascular surgical procedures were planned and <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a> excluded all patients with transcutaneous oxygen tensions of &lt; 30 mmHg. <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a> included patients with diagnosed diabetes, at least one full‐thickness wound below the ankle (Wagner grades III or less) for &gt; 3 month, standard care for &gt; 2 month, TcPO2 &gt; 30 mmHg. <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a> included patients with a diabetic foot ulcer of at least 8 weeks duration, patients with only stage III and IV diabetic foot ulcer and the absence of vascular insufficiency. </p> <p>Overall sample size ranged from 18 participants (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>) to 100 participants (<a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>). Only one trial reported undertaking a sample size calculation, which was for amputation rate (34 in each arm, <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>). There is a possibility that some of the included trials may have been underpowered to detect a statistically significant effect of HBOT on healing or amputation rates. Where baseline ulcer size and duration were reported (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>), there were no between‐group imbalances evident from the published report. </p> <p>Given the different centres involved, the comparator treatment was unlikely to have been exactly the same in any of the trials. One trial did not specify any comparator (<a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>). Sixtrials described a comprehensive and specialised multidisciplinary wound management programme to which HBOT was added for the active arm of the trial (<a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>), and one specified a surgical and dressing regimen common to both arms (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>). </p> <p>The follow‐up periods varied between trials. Two trials reported data immediately following the course of therapy (<a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>), two trials followed patients to discharge from hospital (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>), one followed patients for two weeks after therapy (<a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>), one followed patients for ten weeks or till the ulcers healed (<a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>), two gave results at one year (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>) and one trial followed patients for 22 months (<a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>). All included trials reported at least one outcome of interest. Other outcomes reported included positive wound cultures (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>), number of outpatient visits and cost of wound dressings over one year (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>), vascular responsiveness (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>), transcutaneous oximetry (<a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>) and laser‐Doppler perfusion scans (<a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>). </p> <p>One trial (86 people) compared HBOT to extracorporeal shockwave therapy (ESWT) in a head‐to‐head manner (<a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). Inclusion criteria were people with chronic non‐healing diabetic foot ulcers of greater than three months duration. HBOT was delivered at ATA 2.5 for 90 minutes, five days per week up to 20 treatments. The trial reported the proportion of ulcers healed at the end of treatment, laser‐Doppler perfusion, and cell proliferation and apoptosis. </p> </section> <section id="CD004123-sec-0061"> <h5 class="title">Venous ulcers</h5> <p><a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a> used a treatment session of 2.4 ATA for 90 minutes to a total of 30 sessions over six weeks, and employed an air‐breathing sham treatment on the same schedule. The trial recruited 16 participants who were required to have persistent venous ulcers for more than one year with arterial blood pressures at the ankle and great toe within the normal range when compared with upper limb pressure. The ulcers were matched in pairs by size during the randomisation process, and mean wound areas were similar at the time of entry into the trial. Participants were excluded if they were currently smoking or had chronic illnesses such as diabetes or connective tissue disorders. The recruitment period for this trial is not known, but was over one year. The comparator treatment was not specified. Participants were followed up to 18 weeks from enrolment and data were obtained on wound area and the presence or absence of complete healing. The trial did not report undertaking a sample size calculation and may have been underpowered to detect any statistically significant effect of treatment. </p> </section> <section id="CD004123-sec-0062"> <h5 class="title">Mixed ulcers group</h5> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> included 30 consenting patients with nonhealing ulcers, despite conventional therapy of more than 4 weeks duration and different comorbidities (diabetes, hypertension, varicose vein, vascular insufficiency).The patients were randomized into either the control group (receiving only conventional treatment) or the HBOT group (receiving conventional treatment in addition to HBOT; HBOT was delivered at 2.5 ATA for 90 min, 6 days a week, a total of 30 sessions). The different comorbidities were equally distributed between the experimental and the control group (5 x Diabetes mellitus, 6 x hypertension, 2 x varicose vein, 2 x vascular insufficiency). The study report a sample size calculation for the primary outcome "wound size reduction". Participants were followed until the end of the treatment (30 days). </p> </section> </section> <section id="CD004123-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded 17 trials: six where allocation was not random (<a href="./references#CD004123-bbs2-0021" title="HolbachKH . Indications for and results of hyperbaric oxygenation. Hefte für Unfallheilkunde1978;132:214‐7. ">Holbach 1978</a>; <a href="./references#CD004123-bbs2-0013" title="BaroniG , PorroT , FagliaE , PizziG , MastropasquaA , OrianiG , et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care1987;10:81‐6. ">Baroni 1987</a>; <a href="./references#CD004123-bbs2-0027" title="OrianiG , MeazzaD , FavalesF , PizziGL , AldeghiA , FagliaE . Hyperbaric oxygen therapy in diabetic gangrene. Journal of Hyperbaric Medicine1990;5(3):171‐5. ">Oriani 1990</a>; <a href="./references#CD004123-bbs2-0030" title="ZamboniWA , WongHP , StephensonLL , PfeiferMA . Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea and Hyperbaric Medicine1997;24(3):175‐9. ">Zamboni 1997</a>; <a href="./references#CD004123-bbs2-0022" title="KalaniM , NaderiN , LindF . Hyperbaric oxygen therapy for wound healing and limb salvage in diabetic foot lesions: three year follow‐up. Undersea and Hyperbaric Medicine2000;27(Suppl):44‐5. ">Kalani 2000</a>; <a href="./references#CD004123-bbs2-0023" title="KalaniM , JorneskogG , NaderiN , LindF , BrismarK . Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long‐term follow‐up. Journal of Diabetes and its Complications2002;16(2):153‐8. ">Kalani 2002</a>), two where the intervention of interest was topically applied oxygen (<a href="./references#CD004123-bbs2-0019" title="HengMC , PilgrimJP , BeckFW . A simplified hyperbaric oxygen technique for leg ulcers. Archives of Dermatology1984;120(5):640‐5. ">Heng 1984</a>; <a href="./references#CD004123-bbs2-0020" title="HengMC , HarkerJ , CsathyG , MarshallC , BrazierJ , SumampongS , et al. Angiogenesis in necrotic ulcers treated with hyperbaric oxygen. Ostomy Wound Management2000;46(9):18‐28, 30‐2. ">Heng 2000</a>), three where all participants received HBOT (<a href="./references#CD004123-bbs2-0016" title="DengLL , LinJX . Nursing of diabetic foot treated by oxygen therapy and external application of Long Xue Jie. Academic Journal of Guangzhou Medical College2006;34(3):65‐6. ">Deng 2006</a>; <a href="./references#CD004123-bbs2-0017" title="EfratiS , GallN , BerganJ , FishlevG , BassA , BermanS , et al. Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients. Undersea and Hyperbaric Medicine2009;36(1):1‐12. ">Efrati 2009</a>; <a href="./references#CD004123-bbs2-0024" title="KayaA , AydinF , AltayT , KarapinarL , OzturkH , KarakuzuC . Can major amputation rates be decreased in diabetic foot ulcers with hyperbaric oxygen therapy?. Int Orthop2009;33:441‐6. ">Kaya 2009</a>), one dealing with acute burn wounds (<a href="./references#CD004123-bbs2-0028" title="PerrinsDJ . Influence of hyperbaric oxygen on the survival of split skin grafts. Lancet1967;1(7495):868‐71. ">Perrins 1967</a>), one dealing with pelviperineal necrotising infections <a href="./references#CD004123-bbs2-0015" title="CruzNR . Evaluation of the effect of hyperbaric oxygen therapy in the treatment of pelviperineal necrotizing infections [Avaliaçăo do efeito da oxigenoterapia hiperbárica no tratamento das infecçőes necrosantes pelviperineais]. PhD Thesis. Universidade de São Paulo. Faculdade de Medicina. Departamento de Cirurgia2003. ">Cruz 2003</a>, one which was an animal study (<a href="./references#CD004123-bbs2-0029" title="WhelanHT , BuchmannEV , DhokaliaA , KaneMP , WhelanNT , Wong‐RileyMT , et al. Effect of NASA light‐emitting diode irradiation on molecular changes for wound healing in diabetic mice. Journal of Clinical Laser Medicine and Surgery2001;21(2):67‐74. ">Whelan 2001</a>) and one which was a study protocol with no further information available (<a href="./references#CD004123-bbs2-0026" title="MathieuD , et al. HBO in the treatment of diabetic foot lesions (Study protocol). http://www.oxynet.org/ProtocolsIndex.htm (accessed 27 October 2011). ">Mathieu 2011</a>). Three of the remaining reports were excluded as contributing no appropriate outcome data. (<a href="./references#CD004123-bbs2-0018" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of diabetic foot ulcer. A randomised study. Proceedings of the International Joint Meeting on Hyperbaric and Underwater Medicine. Bologna: Grafica Victoria, 1996:391‐9. ">Faglia 1996b</a>; <a href="./references#CD004123-bbs2-0014" title="ChinK , XieY , AbidiaA , LadenG , GreenmanJ , MonsonJ , et al. The relationship of hyperbaric oxygen therapy and vascular endothelial growth factor in diabetic patients with leg ulcers: a double‐blind randomised controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):63. ">Chin 2001</a>) and an approach to contact the authors did not produce further data (see <a href="./references#CD004123-sec-0129" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD004123-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>We estimated the risk of bias in each of these trials using the 'Risk of bias' tables and the assessments have been graphically represented in <a href="#CD004123-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD004123-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD004123-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD004123-sec-0065"> <h4 class="title">Allocation</h4> <section id="CD004123-sec-0066"> <h5 class="title">Random sequence generation</h5> <p>Five trials (<a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>) described using random number tables to generate the randomisation sequence and we deemed them to be at low risk of bias for this domain. All of the other included trials did not report how the randomisation sequence was generated and we classified them as at unclear risk of bias. </p> </section> <section id="CD004123-sec-0067"> <h5 class="title">Allocation concealment</h5> <p>Information that the allocation process was concealed was provided by the trial author for one trial (<a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>). We classified this trial as being at low risk of bias for this domain. Two trials reported using sealed envelopes but did not report that the envelopes were sequentially numbered and opaque (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>). We classified these and all other included trials as at unclear risk of bias. </p> </section> </section> <section id="CD004123-sec-0068"> <h4 class="title">Blinding</h4> <section id="CD004123-sec-0069"> <h5 class="title">Blinding of participants and personnel</h5> <p>Participants were blind to treatment group allocation in three trials (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>) and we therefore classified them as low risk of bias. One trial reported that participants were not blinded and we classified it as high risk (<a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). One trial does not specify the treatment of the control arm and we assessed this study as unclear risk of bias (<a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>). All other trials did not offer a sham treatment to the control arm and we therefore classified them as high risk of bias (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a>; <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>). </p> </section> <section id="CD004123-sec-0070"> <h5 class="title">Blinding of outcome assessment</h5> <p>Statements that outcome assessors were blind to participant group allocation were reported in three trials that we classified as low risk of bias for this domain (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>). All other included trials did not provide any statement regarding blinding of the outcome assessment and we classified them as at unclear risk of bias. </p> </section> </section> <section id="CD004123-sec-0071"> <h4 class="title">Incomplete outcome data</h4> <section id="CD004123-sec-0072"> <h5 class="title">Incomplete outcome data reported</h5> <p>The number of participants withdrawing/excluded from each treatment arm, along with reasons, was reported in thee trials (<a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>; <a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> reported both an intention‐to‐treat (using all enrolled participants) and a 'per‐protocol' analysis of those receiving at least 35 treatment sessions (11 participants allocated to HBOT and eight to sham). In the other trials there were no withdrawals or loss to follow‐up that appeared in the analysis in any of the trials. One trial reported that all participants completed treatment (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>). We classified these trials as low risk. One trial (<a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>) reported numbers of lost participants during follow‐up, however, without reporting reasons for withdrawal. Therefore, we classified this trial as high risk of bias.All of the other included trials did not provide a statement regarding attrition and we classified them as unclear risk. The numbers of participants lost to final follow‐up are summarised in <a href="#CD004123-tbl-0002">Table 1</a>. Overall, there were 49 participants lost to final follow‐up (8.5% of the total number enrolled). </p> <div class="table" id="CD004123-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Patients missing from final follow‐up</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Missing but included</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Missing total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Per cent of entered</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt;1%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12% ‐ included in ITT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10%</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ITT: intention‐to‐treat</p> </div> </div> </section> <section id="CD004123-sec-0073"> <h5 class="title">Incomplete outcome data addressed</h5> <p>We classified one trial reporting that all recruited participants completed the intervention (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>) as at low risk of bias. One trial reporting attrition of 22% in the HBOT arm presented both a per‐protocol (&gt; 35 treatment sessions) and an intention‐to‐treat analysis (<a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>). We also classified this trial as being at low risk of bias. One trial reported an intention‐to‐treat design, but excluded participants who withdrew from the final analysis (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>), and two trials indicated that some participants who were randomised were not included in the analysis (<a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>). One trial (<a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>) reported numbers of lost participants during follow‐up, however, it is unclear whether the analysis was performed on an intention‐to‐treat basis. We judged these trials as being at high risk of bias. Another trial presenting results for an analysis of completers, reported an imbalance of patient numbers withdrawing and the reasons for withdrawal between treatment arms, this trial was judged to be at high risk of bias (<a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). </p> </section> </section> <section id="CD004123-sec-0074"> <h4 class="title">Selective reporting</h4> <p>We classified one trial for which a protocol was available as being at low risk of bias (<a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>). For another trial, all outcomes detailed on a trials register were presented in the published report (<a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>). We also classified this trial as low risk of bias. For the remainder of the included published trials, no full protocol was available for inspection. As such, we classified all other included trials as unclear risk of bias for this domain. </p> </section> </section> <section id="CD004123-sec-0075"> <h3 class="title" id="CD004123-sec-0075">Effects of interventions</h3> <p>See: <a href="./full#CD004123-tbl-0001"><b>Summary of findings for the main comparison</b> Hyperbaric Oxygen Therapy for chronic wounds</a> </p> <section id="CD004123-sec-0076"> <h4 class="title">Diabetic foot ulcers (10 trials)</h4> <section id="CD004123-sec-0077"> <h5 class="title">Primary outcomes</h5> <p>We did not pre specify in the protocol for this review that we anticipated multiple time points and we have presented data as reported in the included trials. </p> <section id="CD004123-sec-0078"> <h6 class="title">Proportion of ulcers healed at end of treatment period (six weeks)</h6> <p>Five trials reported this outcome (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>; <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>), involving 205 participants (39% of the total people with diabetes in this review), with 99 participants randomised to sham or control and 106 to hyperbaric oxygen therapy (HBOT). The trial by <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a> contributes 75.1% of the weight to this analysis. <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a> reported in both arms of the study no events. Therefore, this study was excluded from this meta‐analysis. There was a statistically significant increase in the proportion of ulcers healed following HBOT compared with control (P = 0.01) (risk ratio (RR) 2.35, 95% confidence interval (CI) 1.19 to 4.62 ; I<sup>2</sup> = 4%) (<a href="./references#CD004123-fig-0002" title="">Analysis 1.1</a>). The pre‐planned sensitivity analysis examining the effect of allocation of drop‐outs suggested a benefit with HBOT in the best‐case scenario but not the worst‐case scenario (best‐case RR 4.61, 95% CI 2.35 to 9.08; P &lt;0.00001, worst‐case RR 0.84, 95% CI 0.51 to 1.37, P = 0.48) (<a href="./references#CD004123-fig-0003" title="">Analysis 1.2</a>; <a href="./references#CD004123-fig-0004" title="">Analysis 1.3</a>). </p> <p>In terms of risk of bias, only two of the trials contributing to these analyses provided detail of the randomisation process (<a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>) and none reported allocation concealment. Only two studies performed blinding of patients (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>) and were considered as low risk; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>; and <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a> were assessed as high risk of performance bias due to study design (no sham therapy). Three were considered to be at low risk of bias in terms of blinded outcome assessment (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>) and two were considered to be at unclear risk (<a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>). Only <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> presented a valid intention‐to treat by including all participants randomised in the final analysis and was considered at low risk of attrition bias. <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a> , <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>, and <a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a> each excluded participants who withdrew from their analyses and were at high risk of bias for this domain. </p> <p>One trial with 41 participants (47 ulcers) assigned to extracorporeal shockwave therapy (ESWT) and 45 participants (47 ulcers) to HBOT (<a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a>) reported this outcome. The unit of analysis reported was ulcers and the investigators reported a per‐protocol analysis showing a statistically significant difference in the proportion of ulcers healed following HBOT compared with ESWT following treatment (P = 0.003). However, as the number of participants healing was not reported the findings could not be confirmed. This trial was considered to be at high risk of performance bias and at high risk of attrition bias as participants who withdrew were excluded from the analysis. </p> </section> <section id="CD004123-sec-0079"> <h6 class="title">Proportion of ulcers healed at six months</h6> <p>Two trials (112 participants) involved 30% of the total diabetic population in this review (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>), with 54 participants randomised to sham or control and 58 to HBOT. There was no significant increase in the proportion of ulcers healed following HBOT (RR 1.70, 95% CI 0.90 to 3.20, P = 0.10, I<sup>2</sup> = 0%) (<a href="./references#CD004123-fig-0005" title="">Analysis 1.4</a>). The sensitivity analysis examining the effect of allocation of drop‐outs suggested a benefit with HBOT only in the best‐case scenario (RR 2.71, 95% CI 1.53 to 4.83, P = 0.0007, I<sup>2</sup> = 0%; worst‐case: RR 0.93, 95% CI 0.57 to 1.54, P = 0.79, I<sup>2</sup> = 24%) (<a href="./references#CD004123-fig-0006" title="">Analysis 1.5</a>; <a href="./references#CD004123-fig-0007" title="">Analysis 1.6</a>). Neither trial reported on the randomisation or allocation process, but both reported that all participants and outcome assessors were blind to treatment allocation. However, only the trial by <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> presented a valid intention‐to ‐treat. </p> </section> <section id="CD004123-sec-0080"> <h6 class="title">Proportion of ulcers healed at one year</h6> <p>Three trials involved 212 participants (58% of the total diabetic participants in this review) (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>), with 104 randomised to sham or control and 108 to HBOT. Two trials reported no ulcers healed in the control arm (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>). A high level of between‐trial heterogeneity was evident for this comparison (I<sup>2</sup> = 85%). In the original review the data was analysed as failure to heal rather than ulcers healed and demonstrated a significant effect in favour of HBOT. For this update, we presented the RR of healing in order to facilitate ease of interpretation for the reader of the healing outcomes. The interpretation of the RR was that a summary estimate in which HBOT increased the occurrence of healing would have a RR &gt; 1.00. The pooled random‐effects model showed no statistically significant difference between the groups (RR 9.53, 95% CI 0.44 to 207.76; P = 0.15) (<a href="./references#CD004123-fig-0008" title="">Analysis 1.7</a>). This change in the result is mainly due to the fact that there are a small number of trials with small sample sizes, two of which have no events in the control arm. We took statistical advice which indicated that this made the random‐effects model for RR of healing unstable in these circumstances and repeated the analysis using a Peto odds ratio (OR) (OR, 7.58, 95% CI 4.33 to 13.29; P &lt;0.00001) (<a href="./references#CD004123-fig-0009" title="">Analysis 1.8</a>). However, we must approach all these results with caution. </p> <p>The sensitivity analysis examining the effect of allocation of drop‐outs shows no statistically significant difference between the two groups in either best‐case or worst‐case scenario (<a href="./references#CD004123-fig-0010" title="">Analysis 1.9</a>; <a href="./references#CD004123-fig-0011" title="">Analysis 1.10</a>). The trial by <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a> was judged to be at overall unclear risk of bias. </p> </section> <section id="CD004123-sec-0081"> <h6 class="title">Proportion of participants requiring major amputation</h6> <p>Five trials (309 participants) reported this outcome at final follow‐up (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> (at discharge); <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a> (seven weeks); <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> (one year) and <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a> (up to 92 weeks)); 159 were randomised to HBOT, 150 to sham or control. There was no statistically significant reduction in amputation rate with the application of HBOT (the RR of major amputation with HBOT was 0.36, 95% CI 0.11 to 1.18, P = 0.08, I<sup>2</sup> = 50%) (<a href="./references#CD004123-fig-0012" title="">Analysis 1.11</a>). This result was sensitive to the assumptions made about drop‐outs (best‐case RR of amputation 0.20, 95% CI 0.10 to 0.38, P &lt; 0.00001, worst‐case 0.62, 95% CI 0.13 to 2.98, P = 0.55) (<a href="./references#CD004123-fig-0013" title="">Analysis 1.12</a>; <a href="./references#CD004123-fig-0014" title="">Analysis 1.13</a>). Subgroup analysis by number of treatments did not significantly affect this outcome, with a RR for amputation after 30 or more treatments of 0.40 (95% CI 0.07 to 2.23, P = 0.29). For &lt; 30 treatments the RR was 0.29, 95% CI 0.07 to 1.16, P = 0.08 (<a href="./references#CD004123-fig-0012" title="">Analysis 1.11</a>). A <i>post hoc</i> subgroup analysis according to the use of sham therapy compared with no sham indicated a significant effect of treatment effect only amongst trials with no sham procedure as control (RR of amputation, HBOT compared with sham 0.47, 95% CI 0.09 to 2.44, P = 0.37; RR HBOT compared to control without sham 0.15, 95% CI 0.06 to 0.36, P &lt; 0.0001) (<a href="./references#CD004123-fig-0015" title="">Analysis 1.14</a>). The trial by <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> was judged to be at high risk of performance bias and all other methodological quality aspects as unclear risk of bias. The trial by <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a> was judged as unclear risk of selection bias, performance bias, detection bias and reporting bias, and as at high risk of performance bias and attrition bias as participants who withdrew were excluded from the analysis. The study by <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a> were considered as high risk of performance bias as the control arm did not receive a sham treatment. </p> </section> </section> <section id="CD004123-sec-0082"> <h5 class="title">Secondary outcomes</h5> <section id="CD004123-sec-0083"> <h6 class="title">Proportion of participants requiring minor amputation</h6> <p>Four trials (242 participants) reported this outcome at final follow‐up (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>), 123 were randomised to HBOT compared with 119 to sham or control. There was no statistically significant change in rates of minor amputation with the application of HBOT (the RR of minor amputation with HBOT was 0.76, 95% CI 0.19 to 3.10, P = 0.71, I<sup>2</sup> = 70%) (<a href="./references#CD004123-fig-0016" title="">Analysis 1.15</a>). This result was not sensitive to the allocation of drop‐outs (best‐case RR of amputation 0.55, 95% CI 0.17 to 1.75, P = 0.31, I<sup>2</sup> = 63%, worst‐case RR 0.91, 95% CI 0.21 to 4.02, P = 0.90, I<sup>2</sup> = 75%) (<a href="./references#CD004123-fig-0017" title="">Analysis 1.16</a>; <a href="./references#CD004123-fig-0018" title="">Analysis 1.17</a>). The analyses for this outcome may be subject to considerable between‐trial heterogeneity as indicated by the high I<sup>2</sup> values (random effects), and these pooled results should be treated with caution. </p> </section> <section id="CD004123-sec-0084"> <h6 class="title">Transcutaneous oxygen tension change in affected foot after treatment</h6> <p>Only one trial contributed results to this outcome (<a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>) involving 70 participants, 36 randomised to HBOT and 34 to a control regimen. Two participants were not included in the analysis (one control, one HBOT). There was a significantly greater increase in transcutaneous oxygen tension following HBOT (HBOT 14 mmHg, sham 5 mmHg, mean difference (MD) 9 mmHg, 95% CI 4.7 to 13.3, P = 0.0001) (<a href="./references#CD004123-fig-0019" title="">Analysis 1.18</a>). However this is a surrogate outcome measure and was not pre specified in the protocol for this review. </p> </section> <section id="CD004123-sec-0085"> <h6 class="title">Absolute transcutaneous oxygen tensions in affected foot after treatment</h6> <p>Three trials (117 participants) (<a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>; <a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>) randomised 62 people to HBOT, 55 to control. <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a> contributed 59% of the participants to this analysis, and four participants were not included in the final analysis (two control, two HBOT). Transcutaneous oxygen tensions in the affected foot were significantly higher in those participants who had received HBOT (HBOT 11.8 mmHg higher, 95% CI 5.7 to 17.8, P = 0.0002, I<sup>2</sup> = 25.4%) (<a href="./references#CD004123-fig-0020" title="">Analysis 1.19</a>). However this is a surrogate outcome measure and was not pre specified in the protocol for this review. </p> </section> <section id="CD004123-sec-0086"> <h6 class="title">Wound size reduction</h6> <p>Two trials (63 participants) reported this outcome (<a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a>). The trial from <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a> (27 participants) suggested ulcer healing was more rapid initially following treatment (after two weeks ulcers in the HBOT group had reduced by 41.8%, compared with 21.7% in the control group). A significant difference was reported (P = 0.04). However, four weeks following the completion of therapy there was no difference in the mean ulcer area reduction between the two groups (HBOT 48.1% versus 41.7%, MD 6.4%, 95% CI ‐15.3 to 28.1) (<a href="./references#CD004123-fig-0021" title="">Analysis 1.20</a>). This is a small trial which did not report a sample size calculation and may have been underpowered to detect any statistically significant effect. Whilst no between‐group differences in mean ulcer size or duration at baseline were evident from the trial report, no covariate adjusted analyses were reported as being undertaken. The trial recruited people with " early diabetic feet", Wagner grades 0, 1 or 2. The addition of the trial from <a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a> to the analysis suggested a statistically significant increased mean ulcer area reduction (P = 0.03) following HBOT compared with control at the end of the treatment (MD 18.10, 95% CI 1.40 to 34.79 ; I<sup>2</sup> = 54%) (<a href="./references#CD004123-fig-0021" title="">Analysis 1.20</a>).This trial contributes to 65.3% of the weight to this analysis. </p> </section> <section id="CD004123-sec-0087"> <h6 class="title">Time to complete healing</h6> <p>No data were available for this outcome.</p> </section> <section id="CD004123-sec-0088"> <h6 class="title">Quality of life</h6> <p>Only one trial reported a quality of life assessment in a subsequent publication to the original article (<a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>). In this trial this outcome was assessed using the 36‐Item Short‐Form Health Survey (<a href="./references#CD004123-bbs2-0075" title="McHorneyCA , WareJEJr , RaczekAE . The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care1993;31:247‐63. ">McHorney 1993</a>) for 23 of 49 participants assigned to HBOT and 10 of 45 participants assigned to control at the one‐year follow‐up. A significant improvement in the physical function role limitations due to emotional health and mental health summary score was reported in the HBOT group (P &lt; 0.05). No statistically significant improvements were reported for any domain amongst the control group. There was no difference between the two groups on the overall physical summary score (MD ‐0.20, 95% CI ‐8.58 to 8.18, P = 0.96), or the overall mental summary score (MD 6.60, 95% CI ‐3.93 to 17.13, P = 0.22) (<a href="./references#CD004123-fig-0022" title="">Analysis 1.21</a>; <a href="./references#CD004123-fig-0023" title="">Analysis 1.22</a>). </p> </section> <section id="CD004123-sec-0089"> <h6 class="title">Recurrence rate</h6> <p>No data were available for this outcome.</p> </section> </section> </section> <section id="CD004123-sec-0090"> <h4 class="title">Venous ulcers (1 trial)</h4> <section id="CD004123-sec-0091"> <h5 class="title">Primary outcomes</h5> <section id="CD004123-sec-0092"> <h6 class="title">Proportion of ulcers healed at 18 weeks</h6> <p>One trial (16 participants) (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>) randomised nine people to HBOT and eight to sham. There was no statistically significant increase in the proportion of ulcers healed in the HBOT group compared with sham treatment (RR 5.00, 95% CI 0.28 to 90.18, P = 0.28) (<a href="./references#CD004123-fig-0024" title="">Analysis 2.1</a>). The sensitivity analysis examining the effect of allocation of drop‐outs using a best‐case (all drop‐outs in active group deemed successes, all drop‐outs in sham group deemed failures) and worse‐case (all drop‐outs in the active group deemed failures, all in the sham group deemed successes) did not alter the result (best‐case RR 9.00, 95% CI 0.56 to 143.89, P = 0.12, worst‐case RR 0.67, 95% CI 0.15 to 2.98, P = 0.60) (<a href="./references#CD004123-fig-0025" title="">Analysis 2.2</a>; <a href="./references#CD004123-fig-0026" title="">Analysis 2.3</a>). </p> <p>In terms of risk of bias, the study did not report methods for the randomization process, for concealment of allocation or for blinding of outcome assessors and was considered to be at unclear risk of bias for these domains. However participants were blinded and there were no withdrawals from the study. </p> </section> </section> <section id="CD004123-sec-0093"> <h5 class="title">Secondary outcomes</h5> <section id="CD004123-sec-0094"> <h6 class="title">Reduction in wound area immediately after treatment (six weeks)</h6> <p><a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a> found a significantly greater reduction in wound area following HBOT. No between‐group differences in mean or median ulcer size were evident at baseline. Ulcer duration at baseline was not reported, although inclusion criteria was for ulcers &gt;1 year. No covariate adjusted analyses were reported. This small trial did not report a sample size calculation and may have been underpowered to detect any statistically significant effect. There was a reduction in wound area in the HBOT group of 35.7% compared with 2.7% in the sham group (MD 33.00%, 95% CI 18.97 to 47.03, P &lt; 0.00001) (<a href="./references#CD004123-fig-0027" title="">Analysis 2.4</a>). </p> </section> <section id="CD004123-sec-0095"> <h6 class="title">Reduction in wound area at 18 weeks</h6> <p><a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a> reported that five participants were not included in this analysis (three sham, two HBOT). There was no significant difference in wound area reduction (HBOT 55.8%, sham 29.6%; MD 29.6%, 95% CI ‐23.0 to 82.2, P = 0.27) (<a href="./references#CD004123-fig-0028" title="">Analysis 2.5</a>). </p> </section> <section id="CD004123-sec-0096"> <h6 class="title">Quality of life, pain reduction and recurrence rates for venous ulcers</h6> <p>No data were available for these outcomes.</p> </section> </section> </section> <section id="CD004123-sec-0097"> <h4 class="title">Mixed ulcers (1 trial)</h4> <section id="CD004123-sec-0098"> <h5 class="title">Primary outcomes</h5> <section id="CD004123-sec-0099"> <h6 class="title">Healed at end of treatment (30 days)</h6> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> enrolled patients with non‐healing diabetic ulcers as well as venous ulcers ("mixed ulcers types") and reported this outcome. The trial involved 30 participants, treated for 30 days, with 15 participants randomised to control and 15 to HBOT. </p> <p>There was no statistically significant increase in the proportion of ulcers healed following HBOT compared with control (P = 0.19) (RR 7.0, 95% CI 0.39 to 124.83) (<a href="./references#CD004123-fig-0002" title="">Analysis 3.1</a>). </p> <p>In terms of risk of bias, the study provided details of the randomization process but did not report methods for concealment of allocation. The study was considered to be at unclear risk of bias in terms of blinding of outcome assessors and high risk of bias in terms of blinding of patients and personnel. No withdrawals were described. </p> </section> <section id="CD004123-sec-0100"> <h6 class="title">Major amputations</h6> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> reported this outcome at the end of treatment (30 days). There was no statistically significant reduction in the amputation rate with the application of HBOT (RR 0.2, 95% CI 0.03 to 1.51, P = 0.12) (<a href="./references#CD004123-fig-0030" title="">Analysis 3.2</a>). </p> </section> </section> <section id="CD004123-sec-0101"> <h5 class="title">Secondary outcomes</h5> <section id="CD004123-sec-0102"> <h6 class="title">Periwound transcutaneous oxygen tensions at the end of treatment</h6> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> reported after 30 days, periwound TcPO2 improved by 11.8 mgHg in the HBOT group (P = 0.01) and decreased by 5.7 mgHg from baseline value in the control group (P = 0.2). The baseline TcPO2 values were not statistically different between both groups (P = 0.407). The periwound transcutaneous oxygen tensions in the affected tissue were significantly higher in those participants who had received HBOT (HBOT 11.8 mmHg higher, 95% CI 5.7 to 17.8, P = 0.0002, I<sup>2</sup> = 25.4%) (<a href="./references#CD004123-fig-0031" title="">Analysis 3.3</a>). </p> </section> <section id="CD004123-sec-0103"> <h6 class="title">Ulcer area reduction (%)</h6> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> found a significantly greater reduction in wound area following HBOT. No between‐group differences in the wound tissue score were evident at baseline. Ulcer duration at baseline was more than 4 weeks with median wound duration of 2 month (interquartile range (IQR) 1‐60) in the HBOT group compared to 2.5 month (IQR 1‐36) in the control group. There was a reduction in wound area in the HBOT group of 59.27% compared with ‐2.61% in the control group (MD 61.88%, 95% CI 41.91 to 81.85, P &lt; 0.00001) (<a href="./references#CD004123-fig-0032" title="">Analysis 3.4</a>). </p> </section> </section> </section> <section id="CD004123-sec-0104"> <h4 class="title">Arterial and pressure ulcers</h4> <p>No eligible trials were identified investigating the use of HBOT for these ulcers.</p> </section> <section id="CD004123-sec-0105"> <h4 class="title">Adverse effects of HBOT</h4> <p>Two trials (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>) stated explicitly that there were no complications or adverse events as a result of HBOT. <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a> reported one person in the HBOT group who was removed from the trial due to barotrauma of the ear and in <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>, two participants were removed from treatment because of claustrophobia ‐ one in each arm of this sham‐controlled trial. <a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> reported in the HBOT group three patients with ear pain, two patients with claustrophobia, one patient with tinnitus, and one patient with headache. The other trials did not report on adverse events or complications of therapy in either arm. </p> </section> <section id="CD004123-sec-0106"> <h4 class="title">Summary of Findings Table</h4> <p>We have included a Summary of Findings table in this review (<a href="./full#CD004123-tbl-0001">summary of findings Table for the main comparison</a>), which gives a concise overview and synthesis of the volume and quality of the evidence. The Summary of Findings table confirms our conclusion that the evidence is of moderate quality and on balance there is no strong evidence of a benefit of using HBOT for healing foot ulcers in people with diabetes. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004123-sec-0107" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004123-sec-0107"></div> <p>This review has included data from twelve trials, ten of which recruited people with diabetic foot ulcers. We believe these represent all randomised controlled trials (RCTs) in this area, both published and unpublished at the time of searching the databases. For the update, we presented a risk ratio (RR) of healing with hyperbaric oxygen therapy (HBOT), as opposed to a RR of failing to heal without HBOT (i.e. control) as presented in the original review. This was undertaken in order to facilitate ease of interpretation of the healing outcomes for users of this review. We found evidence from five trials that the addition of HBOT to a standard wound care regimen results in a significant improvement in wound healing by six weeks (RR 2.35; P = 0.01), but this benefit is not evident at longer‐term follow‐up (RR at one year or longer 9.53; P = 0.15). This was in contrast to this outcome presented as the RR of failing to heal with control, as presented in the original review, which was significant. However, the RR of healing at 12 months presented here should be interpreted with caution given that the analyses included trials of varying sizes, some of which had no healing events in the control arm. As such, the pooled estimation may be unreliable. Although we found some indication amongst the included trials that HBOT may decrease the major amputation rate in people with diabetic foot lesions, our pooled estimate was not statistically significant (RR 0.36, 95% CI 0.11 to 1.18, P = 0.08). </p> <p>We found no evidence that HBOT increases the healing of venous ulcers, arterial or pressure ulcers. </p> <p>Eleven trials with 491 participants in total were eligible for data pooling according to the planned analyses, and a meta‐analysis was not possible for many of the outcomes of interest for this review. Amongst the majority of the included trials, the reporting of a number of aspects of trial conduct to inform the risk of bias assessment was unclear. Only one of the trials reported sufficient detail to indicate in most of the quality aspects low risk of bias (<a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>; <a href="#CD004123-fig-0001">Figure 1</a>). Blinding of participants was only reported in three trials (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>; <a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>) and blinding of outcome assessors was only reported in three trials (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>; <a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a>; <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>). Trials where blinding was not undertaken may have introduced a performance and detection bias to the results. It is not clear which of these factors is the more important in determining the different effect on the risk of major amputation when comparing those who were blinded with those who were not (<a href="./references#CD004123-fig-0015" title="">Analysis 1.14</a>). There is also a possibility that some of the included trials may have been underpowered to detect a statistically significant effect of HBOT on healing or amputation rates. Other limitations that should be considered include the variability in the participant inclusion criteria across trials and the nature and timing of outcome assessments. In particular, there is a possibility of clinical heterogeneity due to differential wound size or severity across trials at participant enrolment. The trial by <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>, for example, excluded all participants at high risk of major amputation. Excluding this trial from the analysis (data not presented) resulted in a significant effect of HBOT on decreasing the risk of major amputation (P = 0.009). </p> <p>The included trials were published over a 22‐year period up to 2014. We had planned to perform subgroup analyses with respect to wound grade at trial enrolment, oxygen dose (treatment profile and number of treatments) and comparator therapy, however the paucity of eligible trials and poor reporting suggested the majority of these analyses would not be informative, and we only performed some subgroup analyses in diabetic ulcer trials. Overall patient inclusion criteria were not standard across trials and were poorly reported in some trials. The oxygen dose at each treatment was fairly consistent across trials, the lowest being 2.2 ATA for some participants in <a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a>, while the highest was 3.0 ATA in <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>. The total number of treatments was similar in all trials except <a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>, where only four treatments were administered over four weeks. While subgroup analysis by treatment number suggests the benefit of HBOT on major amputation rate was significant with either the short course or long course (&gt; 30 treatment course: RR 0.40, P = 0.29; &lt; 30 treatment course: RR 0.29, P = 0.08, ), this result should be interpreted with caution given the contribution of the trial by <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> previously discussed. While all trials included in the meta‐analysis compared HBOT with some form of 'standard' wound care, these comparator therapies were generally poorly described and could not form the basis for a meaningful subgroup analysis with the exception of the analysis of the use of a HBOT sham or no sham as comparator. </p> <p>Pooled data for clinical outcomes of interest could only be performed for diabetic foot lesions with respect to the proportion healed, and the risk of major and minor amputation. The analysis of the rate of major amputation was heterogenous (I<sup>2</sup> = 50%), suggesting a between‐study variance that could not be explained by random variability. The risk of bias of the included trials was variable. The limited reporting of trial methodology in some reports (<a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a>; <a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a>) resulted in an unclear risk of bias associated with the effect estimates these trials contributed to the pooled analyses. There were likely to be clinical differences in the individuals recruited to the included trials. The trial by <a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> excluded participants where major amputation was likely, while the other trials included a wider range of severity. Subgroup analysis by the number of treatment sessions delivered did not assist in the interpretation of this heterogeneity. Furthermore, it is not clear if the surgical decision to amputate was made while blinded to treatment allocation. This is an important potential source of bias and thus a threat to validity. </p> <p>In general, the findings of this review are comparable to those of a previous review (<a href="./references#CD004123-bbs2-0095" title="WangC , SchwaitzbergS , BerlinerE , ZarinD , LauJ . Hyperbaric oxygen for treating wounds: a systematic review of the literature. Archives of Surgery2003;138:272‐9. ">Wang 2003</a>). Wang considered all published comparative trials and case series including at least five participants, and concluded that, while the included trials suggested that HBOT might be of benefit in nonhealing diabetic ulcers, the overall trial quality was poor and there was insufficient evidence to recommend an appropriate time to initiate therapy. Further high‐quality RCTs were recommended to examine short and long‐term risks and benefits. </p> <p>For venous ulceration we retrieved only one small trial (<a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a>) which indicated a significant reduction in wound area at six weeks following the administration of HBOT (33% mean difference (MD) in area ulcerated, 95% CI 19 to 47). This effect did not persist to 18 weeks and there was no significant increase in the proportion of ulcers healed at any time. While this trial suffered considerable data loss at 18 weeks, these results were not sensitive to the allocation of drop‐outs. For arterial and decubitus ulceration we could locate no eligible trials and therefore have no data on which to evaluate the efficacy of HBOT for these ulcers. </p> <p>In this update, we identified one trial (<a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a>) which enrolled patients with different comorbidities and therefore different types of ulcers. Due to the possibility that in future more studies of this types will be found, we decided to add this as a new comparison termed "mixed ulcers types" to the analysis. For this "mixed ulcers" there was a significant benefit of HBOT in terms of reduction in ulcer area at the end of treatment (30 days) but no statistically significant difference in the healing rate of ulcers at the end of treatment or the rate of major amputation. </p> <p>All of these findings are subject to a potential publication bias. While we have made every effort to locate further unpublished data, it remains possible that this review is subject to a positive publication bias, with generally favourable trials more likely to achieve reporting. </p> <p>With regard to long‐term outcomes following HBOT, we have located no relevant data. Only one trial reported a quality of life assessment in a parallel publication (<a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a>), where no between‐group differences in the physical or mental health summary scores of the SF‐36 were evident. However, data were reported only for the completers of the quality of life assessment and as such an attrition bias may be present in the quality of life results. One trial evaluated the economic impact of the application of HBOT (<a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a>) and this trial suggested a saving of GBP 2960 on average per patient in the year following the HBOT. The savings were related to a large reduction in the number of visits required for dressings in the first year (34 versus 137). However, reliability of this analysis is not clear. The methodology was not reported and we have no information regarding the influence of treatment allocation on clinical decisions made during the period of economic evaluation. Therefore, these findings should be handled with caution until more valid data are available. </p> <p>None of the included trials reported major adverse outcomes in either arm, and therefore we can report no data relating to risk with which to balance the benefit estimated. HBOT is regarded as a relatively benign intervention. There are few major adverse effects (pulmonary barotrauma, drug reactions, injuries or death related to chamber fire) and while these are all rare enough not to expect to see them in the trials included in this review, they should be included in consideration of the benefit of this therapy. In practice it is likely that a beneficial effect strong enough to be clearly identified in clinical trials would overwhelm the consideration of such rare events. There are however, a number of more minor complications that may occur commonly and several authors reported on these. Visual disturbance, usually reduction in visual acuity secondary to conformational changes in the lens, is very commonly reported ‐ perhaps as many as 50% of those having a course of 30 treatments (<a href="./references#CD004123-bbs2-0065" title="KhanB , EvansAW , EasterbrookM . Refractive changes in patients undergoing hyperbaric oxygen therapy: a prospective study. Undersea and Hyperbaric Medicine2003;24(Suppl):9. ">Khan 2003</a>). While the great majority of participants recover spontaneously over a period of days to weeks, a small proportion of participants continue to require correction to restore sight to pre‐treatment levels. The second most common adverse effect associated with HBOT is aural barotrauma. Barotrauma can affect any air‐filled cavity in the body (including the middle ear, lungs and respiratory sinuses) and occurs as a direct result of compression. Aural barotrauma is by far the most common as the middle ear air space is small, largely surrounded by bone and the sensitive tympanic membrane, and usually requires active effort by the patient in order to inflate the middle ear through the Eustachian tube on each side. Barotrauma is thus not a consequence of HBOT directly, but rather of the physical conditions required to administer it. Most episodes of barotrauma are mild, easily treated or recover spontaneously and do not require the therapy to be abandoned. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD004123-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD004123-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 1 Healed at end of treatment (6 weeks)." data-id="CD004123-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 1 Healed at end of treatment (6 weeks).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 2 Healed at end of treatment. Best‐case.." data-id="CD004123-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 2 Healed at end of treatment. Best‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 3 Healed at end of treatment. Worst‐case.." data-id="CD004123-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 3 Healed at end of treatment. Worst‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 4 Healed at 6 months." data-id="CD004123-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 4 Healed at 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 5 Healed at 6 months. Best‐case.." data-id="CD004123-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 5 Healed at 6 months. Best‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 6 Healed at 6 months. Worst‐case.." data-id="CD004123-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 6 Healed at 6 months. Worst‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 7 Healed at 1 year." data-id="CD004123-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 7 Healed at 1 year.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 8 Healed at 1 year. Peto analysis method.." data-id="CD004123-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 8 Healed at 1 year. Peto analysis method..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 9 Healed at 1 year. Best‐case.." data-id="CD004123-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 9 Healed at 1 year. Best‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 10 Healed at 1 year. Worst‐case.." data-id="CD004123-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 10 Healed at 1 year. Worst‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 11 Major amputations." data-id="CD004123-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 11 Major amputations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 12 Major amputations. Best‐case.." data-id="CD004123-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 12 Major amputations. Best‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 13 Major amputations. Worst‐case.." data-id="CD004123-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 13 Major amputations. Worst‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 14 Major amputation subgroup by use of sham." data-id="CD004123-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 14 Major amputation subgroup by use of sham.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 15 Minor amputations." data-id="CD004123-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 15 Minor amputations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 16 Minor amputations. Best‐case.." data-id="CD004123-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 16 Minor amputations. Best‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 17 Minor amputations. Worst‐case.." data-id="CD004123-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 17 Minor amputations. Worst‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 18 Transcutaneous oxygen tensions change after treatment." data-id="CD004123-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 18 Transcutaneous oxygen tensions change after treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 19 Absolute difference in transcutaneous oxygen at end of treatment." data-id="CD004123-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 19 Absolute difference in transcutaneous oxygen at end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 20 Ulcer area reduction (%)." data-id="CD004123-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 20 Ulcer area reduction (%).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 21 Quality of life ‐ SF‐36 physical summary score." data-id="CD004123-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 21 Quality of life ‐ SF‐36 physical summary score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Diabetic ulcers, Outcome 22 Quality of life ‐ SF‐36 mental summary score." data-id="CD004123-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Diabetic ulcers, Outcome 22 Quality of life ‐ SF‐36 mental summary score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Venous ulcers, Outcome 1 Healed at 18 weeks." data-id="CD004123-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Venous ulcers, Outcome 1 Healed at 18 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Venous ulcers, Outcome 2 Healed at 18 weeks. Best‐case.." data-id="CD004123-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Venous ulcers, Outcome 2 Healed at 18 weeks. Best‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Venous ulcers, Outcome 3 Healed at 18 weeks. Worst‐case.." data-id="CD004123-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Venous ulcers, Outcome 3 Healed at 18 weeks. Worst‐case..</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Venous ulcers, Outcome 4 Wound size reduction at end treatment (6 weeks)." data-id="CD004123-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Venous ulcers, Outcome 4 Wound size reduction at end treatment (6 weeks).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Venous ulcers, Outcome 5 Wound size reduction at 18 weeks." data-id="CD004123-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Venous ulcers, Outcome 5 Wound size reduction at 18 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mixed ulcers types, Outcome 1 Healed at end of treatment (30 days)." data-id="CD004123-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Mixed ulcers types, Outcome 1 Healed at end of treatment (30 days).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mixed ulcers types, Outcome 2 Major amputations." data-id="CD004123-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Mixed ulcers types, Outcome 2 Major amputations.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mixed ulcers types, Outcome 3 Periwound transcutaneous oxygen tensions at the end of treatment." data-id="CD004123-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Mixed ulcers types, Outcome 3 Periwound transcutaneous oxygen tensions at the end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004123-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/urn:x-wiley:14651858:media:CD004123:CD004123-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_t/tCD004123-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Mixed ulcers types, Outcome 4 Ulcer area reduction (%)." data-id="CD004123-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Mixed ulcers types, Outcome 4 Ulcer area reduction (%).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/media/CDSR/CD004123/image_n/nCD004123-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004123-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperbaric Oxygen Therapy for chronic wounds</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hyperbaric Oxygen Therapy for chronic wounds</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with chronic wounds<br/> <b>Settings:</b> inpatients and outpatients in a hyperbaric facility<br/> <b>Intervention:</b> Hyperbaric Oxygen Therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Hyperbaric Oxygen Therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Diabetic ulcers healed at 1 year.</b><br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 9.53</b> <br/> (0.44 to 207.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>212<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>115 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1000 per 1000</b><br/> (51 to 1000) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Diabetic ulcers ‐ major amputations</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.36</b> <br/> (0.11 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>312<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>89 per 1000</b><br/> (27 to 284) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Analysis comprises small studies, some with zero events in control arm<br/> <sup>2</sup> small sample size<br/> <sup>3</sup> very large effect: RR &gt;5 </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperbaric Oxygen Therapy for chronic wounds</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004123-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Patients missing from final follow‐up</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Missing but included</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Missing total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Per cent of entered</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0008" title="KhandelwalS , ChaudharyP , PoddarD D , SaxenaN , SinghR A , BiswalU C . Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Clin Pract2013;3:e9. ">Khandelwal 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0006" title="KaurS , PawarM , BanerjeeN , GargR . Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol2012;28:70‐5. ">Kaur 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0011" title="MaL , LiP , ShiZ , HouT , ChenX , DuJ . A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage2013;59:18‐24. ">Ma 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0002" title="DoctorN , PandyaS , SupeA . Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine1992;38(3):112‐4. ">Doctor 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0004" title="FagliaE , FavalesF , AldeghiA , CaliaP , QuarantielloA , OrianiG , et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care1996;19(12):1338‐43. ">Faglia 1996a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0009" title="LinTF , ChenSB , NiuKC . The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea and Hyperbaric Medicine2001;28(Suppl):67. ">Lin 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0001" title="AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Hyperbaric oxygen therapy for diabetic leg ulcers ‐ a double‐blind randomised‐controlled trial. Undersea and Hyperbaric Medicine2001;28(Suppl):64. AbidiaA , KuhanG , LadenG , BahiaH , JohnsonB , WilkinsonA , et al. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. British Journal of Surgery2001;88(5):744. AbidiaA , KuhanG , LadenG , et al. The role of hyperbaric oxygen therapy in ischaemic, diabetic, lower‐extremity ulcers: a double‐blind randomized controlled study. Undersea and Hyperbaric Medicine2001;28:48. AbidiaA , LadenG , KuhanG , JohnsonBF , WilkinsonAR , RenwickPM , et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double‐blind randomised‐controlled trial. European Journal of Vascular and Endovascular Surgery2003;25:513‐8. ">Abidia 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0005" title="HammarlundC , SundbergT . Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plastic and Reconstructive Surgery1994;93(4):829‐33. ">Hammarlund 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0007" title="KesslerL , BilbaultP , OrtégaF , GrassoC , PassemardR , StephanD , et al. Hyperbaric oxygen accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care2003;26:2378‐82. ">Kessler 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt;1%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0003" title="DuzgunAP , SatirHZ , OzozanO , SaylamB , KulahB , CoskunF . Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008;47(6):515‐9. ">Duzgun 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0010" title="LöndahlM , Landin‐OlssonM , KatzmanP . Hyperbaric oxygen therapy improves health‐related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine2011;28(2):186‐90. LöndahlM , NilssonA , KatzmanP , HammarlundC . Hyperbaric oxygen therapy as adjunctive treatment of chronic diabetic foot ulcers. Diabetes Care2010;33(5):998‐1003. ">Londahl 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12% ‐ included in ITT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004123-bbs2-0012" title="WangC‐J , WuR‐W , YangY‐J . Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Research and Clinical Practice2011;92(2):187‐93. ">Wang 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ITT: intention‐to‐treat</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Patients missing from final follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/full#CD004123-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004123-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Diabetic ulcers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Healed at end of treatment (6 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.35 [1.19, 4.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Healed at end of treatment. Best‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.61 [2.35, 9.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Healed at end of treatment. Worst‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.51, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Healed at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.90, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Healed at 6 months. Best‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [1.53, 4.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Healed at 6 months. Worst‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.57, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Healed at 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.53 [0.44, 207.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Healed at 1 year. Peto analysis method. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.58 [4.33, 13.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Healed at 1 year. Best‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.17 [0.47, 220.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Healed at 1 year. Worst‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.55 [0.42, 101.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Major amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.11, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Subgroup (30+ treatments)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.07, 2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Subgroup (&lt; 30 treatments)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.07, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Major amputations. Best‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.10, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Major amputations. Worst‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.13, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Major amputation subgroup by use of sham <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Sham HBOT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.09, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 No sham</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.06, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Minor amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.19, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Minor amputations. Best‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.17, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Minor amputations. Worst‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.21, 4.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Transcutaneous oxygen tensions change after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.0 [4.68, 13.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Absolute difference in transcutaneous oxygen at end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.76 [5.68, 17.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Ulcer area reduction (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>18.10 [1.40, 34.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Quality of life ‐ SF‐36 physical summary score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐8.58, 8.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Quality of life ‐ SF‐36 mental summary score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [‐3.93, 17.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Diabetic ulcers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004123-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Venous ulcers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Healed at 18 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.28, 90.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Healed at 18 weeks. Best‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.0 [0.56, 143.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Healed at 18 weeks. Worst‐case. <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.15, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Wound size reduction at end treatment (6 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>33.0 [18.97, 47.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Wound size reduction at 18 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>29.60 [‐22.99, 82.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Venous ulcers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004123-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Mixed ulcers types</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Healed at end of treatment (30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.0 [0.39, 124.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Major amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.03, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Periwound transcutaneous oxygen tensions at the end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.90 [4.00, 21.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Ulcer area reduction (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>61.88 [41.91, 81.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Mixed ulcers types</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004123.pub4/references#CD004123-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004123.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004123-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004123-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD004123-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD004123-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD004123-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD004123-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="ta#CD004123-note-0005">தமிழ்</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004123-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004123\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004123\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004123\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004123\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004123\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004123.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004123.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004123.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004123.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004123.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724322433"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004123.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724322437"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004123.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e600099d1f409',t:'MTc0MDcyNDMyMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 